1349 is the total number of securities PURA VIDA INVESTMENTS, LLC has owned. The longest PURA VIDA INVESTMENTS, LLC has owned a single stock is 26 quarters.
Period | Weighting | Quarter | |||||||
---|---|---|---|---|---|---|---|---|---|
Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
ICUI | ICU MED INC | 22 | 4 | 0.32% | 1.89% | 4.18% | Q4 2016 | Q2 2023 | 26 |
NSTG | NANOSTRING TECHNOLOGIE... | 21 | 5 | 0.37% | 1.74% | 3.32% | Q3 2016 | Q2 2023 | 26 |
VRAY | VIEWRAY INC | 25 | 25 | 0.34% | 1.61% | 3.23% | Q2 2017 | Q2 2023 | 25 |
LIVN | LIVANOVA PLC | 12 | 1 | 0.33% | 1.57% | 3.77% | Q4 2015 | Q3 2023 | 23 |
ALXN | ALEXION PHARMACEUTICAL... | 8 | 7 | 0.33% | 1.46% | 4.26% | Q4 2014 | Q1 2021 | 23 |
INSP | INSPIRE MED SYS INC | 22 | 22 | 1.20% | 2.26% | 3.73% | Q2 2018 | Q3 2023 | 22 |
BSX | BOSTON SCIENTIFIC CORP | 19 | 1 | 0.11% | 2.09% | 4.81% | Q4 2014 | Q3 2022 | 22 |
IVC | INVACARE CORP | 11 | 11 | 0.16% | 1.19% | 2.84% | Q1 2016 | Q3 2021 | 22 |
ESTA | ESTABLISHMENT LABS HLD... | 21 | 21 | 1.05% | 2.44% | 5.02% | Q3 2018 | Q3 2023 | 21 |
XENT | INTERSECT ENT INC | 18 | 1 | 0.28% | 1.22% | 2.55% | Q4 2015 | Q2 2021 | 21 |
DXCM | DEXCOM INC | 16 | 1 | 0.26% | 0.89% | 1.73% | Q1 2017 | Q3 2023 | 21 |
STAA | STAAR SURGICAL CO | 19 | 1 | 0.08% | 1.17% | 2.40% | Q2 2015 | Q4 2022 | 20 |
XLV | SELECT SECTOR SPDR TR | 7 | 2 | 0.92% | 3.25% | 7.92% | Q4 2015 | Q1 2021 | 19 |
FXH | FIRST TR EXHANGE TRADE... | 11 | 2 | 0.74% | 2.41% | 6.19% | Q4 2015 | Q1 2021 | 19 |
GH | GUARDANT HEALTH INC | 13 | 2 | 0.13% | 0.59% | 1.25% | Q4 2018 | Q3 2023 | 18 |
APYX | APYX MEDICAL CORPORATION | 18 | 18 | 0.07% | 0.36% | 0.66% | Q2 2019 | Q3 2023 | 18 |
BAX | BAXTER INTL INC | 16 | 1 | 0.47% | 2.18% | 5.12% | Q1 2015 | Q3 2019 | 17 |
ATRC | ATRICURE INC | 11 | 1 | 0.24% | 0.97% | 2.96% | Q4 2015 | Q1 2023 | 17 |
SPY | SPDR S&P 500 ETF TR | 6 | 1 | 0.93% | 9.36% | 24.54% | Q4 2015 | Q1 2021 | 16 |
IWM | ISHARES TR | 12 | 2 | 1.52% | 5.67% | 11.36% | Q4 2016 | Q1 2021 | 16 |
ZBH | ZIMMER BIOMET HOLDINGS... | 11 | 1 | 0.25% | 1.37% | 2.86% | Q4 2015 | Q3 2021 | 16 |
AGN | ALLERGAN PLC | 7 | 1 | 0.52% | 1.48% | 5.18% | Q3 2015 | Q4 2019 | 15 |
OCX | ONCOCYTE CORP | 15 | 15 | 0.30% | 0.97% | 2.18% | Q4 2019 | Q2 2023 | 15 |
QTNT | QUOTIENT LTD | 15 | 15 | 0.05% | 0.52% | 0.91% | Q1 2019 | Q3 2022 | 15 |
XBI | SPDR SER TR | 7 | 1 | 0.64% | 3.33% | 6.38% | Q4 2014 | Q1 2021 | 14 |
GKOS | GLAUKOS CORP | 6 | 1 | 0.14% | 1.47% | 4.51% | Q4 2016 | Q3 2023 | 14 |
NTRA | NATERA INC | 6 | 1 | 0.12% | 0.75% | 2.08% | Q3 2018 | Q3 2023 | 14 |
RCM | R1 RCM INC | 13 | 1 | 0.06% | 0.70% | 1.24% | Q3 2018 | Q1 2022 | 14 |
OTIC | OTONOMY INC | 12 | 2 | 0.13% | 0.42% | 0.94% | Q1 2017 | Q3 2020 | 14 |
SVRA | SAVARA INC | 8 | 2 | 0.00% | 0.09% | 0.47% | Q2 2017 | Q4 2022 | 14 |
SIEN | SIENTRA INC | 6 | 1 | 0.23% | 1.36% | 2.87% | Q4 2014 | Q1 2019 | 13 |
QTRX | QUANTERIX CORP | 6 | 1 | 0.01% | 1.12% | 4.93% | Q4 2017 | Q3 2023 | 13 |
OM | OUTSET MED INC | 13 | 13 | 0.28% | 0.82% | 1.71% | Q3 2020 | Q3 2023 | 13 |
TELA | TELA BIO INC | 13 | 13 | 0.17% | 0.30% | 0.54% | Q3 2020 | Q3 2023 | 13 |
TGTX | TG THERAPEUTICS INC | 6 | 1 | 0.04% | 0.26% | 0.47% | Q1 2018 | Q4 2022 | 13 |
CUTR | CUTERA INC | 11 | 1 | 0.18% | 1.76% | 2.92% | Q3 2020 | Q3 2023 | 12 |
PODD | INSULET CORP | 8 | 1 | 0.13% | 1.60% | 3.02% | Q4 2014 | Q3 2023 | 12 |
LUNG | PULMONX CORP | 12 | 12 | 0.44% | 0.83% | 1.42% | Q4 2020 | Q3 2023 | 12 |
COO | COOPER COS INC | 6 | 1 | 0.18% | 0.82% | 2.26% | Q1 2015 | Q2 2023 | 12 |
AMRN | AMARIN CORP PLC | 4 | 1 | 0.02% | 0.52% | 1.06% | Q1 2016 | Q4 2021 | 12 |
LYRA | LYRA THERAPEUTICS INC | 10 | 2 | 0.07% | 0.41% | 1.04% | Q2 2020 | Q3 2023 | 12 |
FLDM | STANDARD BIOTOOLS INC | 6 | 1 | 0.02% | 0.40% | 1.17% | Q1 2016 | Q3 2022 | 12 |
SDGR | SCHRODINGER INC | 7 | 5 | 0.06% | 0.32% | 0.55% | Q3 2020 | Q3 2023 | 12 |
ADPT | ADAPTIVE BIOTECHNOLOGI... | 8 | 1 | 0.07% | 0.31% | 0.64% | Q2 2019 | Q2 2023 | 12 |
FOMX | FOAMIX PHARMACEUTICALS... | 12 | 12 | 0.04% | 0.22% | 0.56% | Q3 2015 | Q2 2018 | 12 |
NXTM | NXSTAGE MEDICAL INC | 11 | 11 | 0.79% | 1.95% | 2.79% | Q4 2014 | Q2 2017 | 11 |
WMGI | WRIGHT MED GROUP N V | 6 | 5 | 0.56% | 1.21% | 1.90% | Q4 2015 | Q2 2019 | 11 |
NSTG | NANOSTRING TECHNOLOGIE... | 6 | 2 | 0.09% | 0.84% | 2.62% | Q3 2017 | Q4 2020 | 11 |
KIDS | ORTHOPEDIATRICS CORP | 11 | 11 | 0.22% | 0.74% | 1.04% | Q2 2018 | Q4 2020 | 11 |
XENT | INTERSECT ENT INC | 4 | 1 | 0.05% | 0.66% | 2.25% | Q2 2016 | Q1 2021 | 11 |
TXG | 10X GENOMICS INC | 11 | 11 | 0.06% | 0.39% | 0.78% | Q3 2019 | Q1 2022 | 11 |
MDVL | MEDAVAIL HOLDINGS INC | 11 | 11 | 0.00% | 0.27% | 1.34% | Q4 2020 | Q2 2023 | 11 |
AVDL | AVADEL PHARMACEUTICALS... | 8 | 3 | 0.02% | 0.15% | 0.47% | Q3 2019 | Q4 2022 | 11 |
GOSSAMER BIO INC | 11 | 11 | 0.01% | 0.02% | 0.05% | Q2 2020 | Q4 2022 | 11 | |
ABBV | ABBVIE INC | 4 | 1 | 0.39% | 1.76% | 3.45% | Q2 2015 | Q3 2022 | 10 |
ICUI | ICU MED INC | 8 | 2 | 0.21% | 1.36% | 4.12% | Q2 2018 | Q1 2021 | 10 |
TMO | THERMO FISHER SCIENTIF... | 3 | 1 | 0.26% | 1.04% | 1.93% | Q4 2014 | Q1 2021 | 10 |
UTHR | UNITED THERAPEUTICS CO... | 6 | 2 | 0.05% | 0.67% | 1.52% | Q4 2017 | Q4 2022 | 10 |
ZGNX | ZOGENIX INC | 7 | 3 | 0.20% | 0.66% | 2.18% | Q4 2015 | Q1 2019 | 10 |
RCEL | AVITA MEDICAL INC | 7 | 3 | 0.14% | 0.49% | 1.33% | Q1 2021 | Q3 2023 | 10 |
ALQA | ALLIQUA BIOMEDICAL INC | 10 | 10 | 0.13% | 0.42% | 1.07% | Q1 2015 | Q2 2017 | 10 |
ARAY | ACCURAY INC | 3 | 1 | 0.02% | 0.39% | 0.90% | Q2 2015 | Q2 2019 | 10 |
CPRX | CATALYST PHARM PARTNES... | 4 | 2 | 0.07% | 0.39% | 1.00% | Q4 2014 | Q2 2020 | 10 |
CYTOKINETICS INC | 10 | 10 | 0.16% | 0.33% | 0.57% | Q1 2020 | Q2 2022 | 10 | |
STXS | STEREOTAXIS INC | 10 | 10 | 0.11% | 0.28% | 0.44% | Q4 2019 | Q1 2022 | 10 |
BCRX | BIOCRYST PHARMACEUTICA... | 3 | 1 | 0.06% | 0.22% | 0.66% | Q2 2017 | Q4 2022 | 10 |
GNLN | GREENLANE HLDGS INC | 10 | 10 | 0.03% | 0.21% | 0.70% | Q2 2019 | Q3 2021 | 10 |
MIST | MILESTONE PHARMACEUTIC... | 10 | 10 | 0.04% | 0.17% | 0.35% | Q3 2020 | Q4 2022 | 10 |
TALKW | TALKSPACE INC | 10 | 10 | 0.00% | 0.01% | 0.02% | Q2 2021 | Q3 2023 | 10 |
MAPSW | WM TECHNOLOGY INC | 10 | 10 | 0.00% | 0.00% | 0.01% | Q2 2021 | Q3 2023 | 10 |
ISHARES TR | 7 | 2 | 3.99% | 5.82% | 8.36% | Q2 2021 | Q3 2023 | 9 | |
FIRST TR EXCHANGE TRAD... | 7 | 2 | 0.74% | 2.34% | 4.45% | Q2 2021 | Q3 2023 | 9 | |
ATHN | ATHENAHEALTH INC | 5 | 4 | 1.34% | 2.25% | 3.66% | Q1 2016 | Q2 2018 | 9 |
SPDR SER TR | 7 | 2 | 1.14% | 2.15% | 4.06% | Q2 2021 | Q3 2023 | 9 | |
GMED | GLOBUS MED INC | 8 | 1 | 0.56% | 1.98% | 3.97% | Q4 2016 | Q1 2019 | 9 |
ARK ETF TR | 7 | 2 | 0.95% | 1.57% | 3.35% | Q2 2021 | Q3 2023 | 9 | |
ARK ETF TR | 7 | 2 | 0.98% | 1.54% | 2.44% | Q2 2021 | Q3 2023 | 9 | |
LLY | LILLY ELI & CO | 6 | 1 | 0.05% | 1.35% | 2.28% | Q2 2015 | Q3 2022 | 9 |
JAZZ | JAZZ PHARMACEUTICALS PLC | 4 | 1 | 0.20% | 1.11% | 2.90% | Q4 2014 | Q2 2022 | 9 |
CNMD | CONMED CORP | 4 | 1 | 0.24% | 0.78% | 2.43% | Q1 2015 | Q1 2021 | 9 |
CUTERA INC | 7 | 2 | 0.11% | 0.50% | 1.42% | Q2 2021 | Q3 2023 | 9 | |
IMMU | IMMUNOMEDICS INC | 6 | 1 | 0.08% | 0.48% | 1.04% | Q1 2016 | Q3 2020 | 9 |
VRTX | VERTEX PHARMACEUTICALS... | 6 | 1 | 0.04% | 0.47% | 1.33% | Q3 2017 | Q4 2022 | 9 |
PACB | PACIFIC BIOSCIENCES CA... | 6 | 1 | 0.04% | 0.43% | 0.73% | Q3 2018 | Q3 2023 | 9 |
MSON | MISONIX INC | 7 | 2 | 0.17% | 0.31% | 0.48% | Q2 2019 | Q3 2021 | 9 |
OCRX | OCERA THERAPEUTICS INC | 9 | 9 | 0.11% | 0.19% | 0.24% | Q4 2014 | Q4 2016 | 9 |
ARDX | ARDELYX INC | 5 | 1 | 0.00% | 0.16% | 0.38% | Q1 2017 | Q3 2022 | 9 |
GHRS | GH RESEARCH PLC | 9 | 9 | 0.02% | 0.13% | 0.27% | Q2 2021 | Q2 2023 | 9 |
NYXOAH S A | 9 | 9 | 0.04% | 0.13% | 0.20% | Q3 2021 | Q3 2023 | 9 | |
SOMALOGIC INC | 9 | 9 | 0.00% | 0.01% | 0.02% | Q3 2021 | Q3 2023 | 9 | |
INVESCO QQQ TR | 4 | 2 | 1.93% | 5.48% | 9.26% | Q2 2021 | Q3 2023 | 8 | |
ABT | ABBOTT LABS | 3 | 1 | 1.25% | 1.98% | 2.63% | Q3 2015 | Q1 2018 | 8 |
LIVANOVA PLC | 6 | 2 | 0.24% | 1.56% | 3.15% | Q3 2021 | Q3 2023 | 8 | |
INOV | INOVALON HLDGS INC | 8 | 8 | 0.21% | 1.38% | 2.18% | Q3 2019 | Q2 2021 | 8 |
UNH | UNITEDHEALTH GROUP INC | 4 | 4 | 0.40% | 1.37% | 2.43% | Q1 2019 | Q1 2021 | 8 |
STRYKER CORPORATION | 5 | 1 | 0.40% | 1.30% | 3.41% | Q2 2021 | Q3 2023 | 8 | |
GLAUKOS CORP | 6 | 2 | 0.34% | 1.30% | 2.17% | Q3 2021 | Q3 2023 | 8 | |
PEN | PENUMBRA INC | 6 | 1 | 0.24% | 1.21% | 2.22% | Q3 2015 | Q3 2021 | 8 |
ZBH | ZIMMER BIOMET HOLDINGS... | 3 | 1 | 0.12% | 1.06% | 3.18% | Q3 2018 | Q1 2021 | 8 |
ARAY | ACCURAY INC | 4 | 1 | 0.26% | 1.04% | 2.04% | Q2 2015 | Q1 2018 | 8 |
KITE | KITE PHARMA INC | 8 | 8 | 0.78% | 1.02% | 1.55% | Q4 2014 | Q3 2016 | 8 |
INCY | INCYTE CORP | 5 | 1 | 0.14% | 0.85% | 2.66% | Q4 2017 | Q3 2020 | 8 |
SGYPQ | SYNERGY PHARMACEUTICAL... | 8 | 8 | 0.28% | 0.78% | 1.21% | Q4 2014 | Q3 2016 | 8 |
INCY | INCYTE CORP | 3 | 1 | 0.13% | 0.55% | 1.71% | Q3 2017 | Q4 2022 | 8 |
OLK | OLINK HLDG AB | 5 | 3 | 0.25% | 0.45% | 0.90% | Q1 2021 | Q3 2023 | 8 |
SONENDO INC | 8 | 8 | 0.06% | 0.41% | 0.84% | Q4 2021 | Q3 2023 | 8 | |
SRPT | SAREPTA THERAPEUTICS INC | 4 | 4 | 0.04% | 0.32% | 0.79% | Q1 2015 | Q4 2020 | 8 |
AMRS | AMYRIS INC | 4 | 1 | 0.08% | 0.30% | 0.54% | Q2 2019 | Q3 2022 | 8 |
EXEL | EXELIXIS INC | 3 | 1 | 0.03% | 0.27% | 1.02% | Q4 2017 | Q4 2022 | 8 |
BVS | BIOVENTUS INC | 8 | 8 | 0.00% | 0.24% | 0.38% | Q1 2021 | Q4 2022 | 8 |
STDY | STEADYMED LTD | 8 | 8 | 0.04% | 0.23% | 0.54% | Q2 2016 | Q1 2018 | 8 |
SOPHIA GENETICS SA | 7 | 1 | 0.08% | 0.22% | 0.43% | Q3 2021 | Q3 2023 | 8 | |
MASS | 908 DEVICES INC | 8 | 8 | 0.05% | 0.22% | 0.35% | Q4 2020 | Q3 2022 | 8 |
ADMP | ADAMIS PHARMACEUTICALS... | 7 | 1 | 0.16% | 0.21% | 0.28% | Q1 2015 | Q1 2017 | 8 |
KALV | KALVISTA PHARMACEUTICA... | 8 | 8 | 0.01% | 0.19% | 0.70% | Q1 2021 | Q4 2022 | 8 |
FPRX | FIVE PRIME THERAPEUTIC... | 6 | 2 | 0.01% | 0.17% | 0.26% | Q4 2015 | Q3 2020 | 8 |
HSAQ | HEALTH SCIENCES ACQ CO... | 8 | 8 | 0.03% | 0.04% | 0.06% | Q3 2020 | Q2 2022 | 8 |
SRRA | SIERRA ONCOLOGY INC | 8 | 8 | 0.01% | 0.03% | 0.06% | Q1 2020 | Q4 2021 | 8 |
SPDR S&P 500 ETF TR | 4 | 1 | 2.58% | 7.36% | 12.99% | Q2 2021 | Q2 2023 | 7 | |
ISHARES TR | 5 | 2 | 2.15% | 3.31% | 4.13% | Q4 2021 | Q3 2023 | 7 | |
BIOGEN INC | 7 | 7 | 0.25% | 2.00% | 4.13% | Q2 2021 | Q4 2022 | 7 | |
PFE | PFIZER INC | 5 | 1 | 0.13% | 1.93% | 3.49% | Q2 2015 | Q3 2022 | 7 |
NUVA | NUVASIVE INC | 5 | 1 | 0.64% | 1.81% | 2.65% | Q4 2014 | Q4 2016 | 7 |
MRK | MERCK & CO. INC | 2 | 1 | 0.07% | 1.56% | 3.31% | Q2 2017 | Q4 2021 | 7 |
METTLER TOLEDO INTERNA... | 5 | 2 | 0.42% | 1.17% | 2.35% | Q3 2021 | Q3 2023 | 7 | |
INTUITIVE SURGICAL INC | 4 | 1 | 0.47% | 1.12% | 2.29% | Q2 2021 | Q3 2023 | 7 | |
ICU MED INC | 4 | 1 | 0.43% | 0.94% | 2.03% | Q2 2021 | Q2 2023 | 7 | |
GILD | GILEAD SCIENCES INC | 3 | 1 | 0.09% | 0.90% | 1.62% | Q4 2014 | Q1 2021 | 7 |
AKRXQ | AKORN INC | 7 | 7 | 0.30% | 0.87% | 1.45% | Q1 2015 | Q3 2016 | 7 |
ISEE | IVERIC BIO INC | 7 | 7 | 0.01% | 0.54% | 1.31% | Q2 2021 | Q4 2022 | 7 |
INOV | INOVALON HLDGS INC | 7 | 7 | 0.18% | 0.53% | 0.94% | Q3 2019 | Q1 2021 | 7 |
LNTH | LANTHEUS HLDGS INC | 7 | 7 | 0.26% | 0.44% | 0.81% | Q2 2021 | Q4 2022 | 7 |
MASI | MASIMO CORP | 5 | 1 | 0.17% | 0.42% | 0.85% | Q4 2018 | Q2 2023 | 7 |
NOVOCURE LTD | 7 | 7 | 0.17% | 0.41% | 1.00% | Q2 2021 | Q4 2022 | 7 | |
QUANTERIX CORP | 2 | 1 | 0.18% | 0.37% | 0.79% | Q2 2021 | Q3 2023 | 7 | |
PSNL | PERSONALIS INC | 6 | 1 | 0.11% | 0.36% | 0.59% | Q2 2019 | Q3 2021 | 7 |
VIEWRAY INC | 4 | 1 | 0.11% | 0.34% | 0.86% | Q2 2021 | Q2 2023 | 7 | |
CDXS | CODEXIS INC | 7 | 7 | 0.20% | 0.33% | 0.52% | Q4 2020 | Q2 2022 | 7 |
TRUPANION INC | 7 | 7 | 0.09% | 0.33% | 0.65% | Q2 2021 | Q4 2022 | 7 | |
WMGIZ | WRIGHT MED GROUP N V | 7 | 7 | 0.23% | 0.29% | 0.34% | Q4 2015 | Q2 2017 | 7 |
ALDX | ALDEYRA THERAPEUTICS INC | 7 | 7 | 0.11% | 0.20% | 0.27% | Q2 2015 | Q4 2016 | 7 |
CLDX | CELLDEX THERAPEUTICS I... | 5 | 2 | 0.10% | 0.16% | 0.31% | Q2 2020 | Q1 2022 | 7 |
ICAD | ICAD INC | 5 | 2 | 0.05% | 0.13% | 0.24% | Q1 2021 | Q1 2023 | 7 |
KURA | KURA ONCOLOGY INC | 6 | 1 | 0.04% | 0.12% | 0.32% | Q4 2017 | Q4 2021 | 7 |
GOSS | GOSSAMER BIO INC | 7 | 7 | 0.02% | 0.06% | 0.24% | Q1 2021 | Q3 2022 | 7 |
PHAT | PHATHOM PHARMACEUTICAL... | 7 | 7 | 0.03% | 0.06% | 0.07% | Q4 2020 | Q2 2022 | 7 |
VINC | VINCERX PHARMA INC | 7 | 7 | 0.01% | 0.05% | 0.11% | Q4 2020 | Q2 2022 | 7 |
MDT | MEDTRONIC PLC | 2 | 2 | 0.85% | 3.18% | 7.26% | Q3 2018 | Q4 2020 | 6 |
UHS | UNIVERSAL HLTH SVCS INC | 5 | 1 | 2.02% | 3.06% | 4.62% | Q2 2015 | Q1 2017 | 6 |
TFX | TELEFLEX INC | 5 | 1 | 1.07% | 2.57% | 4.08% | Q1 2015 | Q1 2017 | 6 |
IHI | ISHARES TR | 3 | 1 | 0.77% | 2.49% | 4.79% | Q1 2019 | Q4 2020 | 6 |
ABT | ABBOTT LABS | 2 | 1 | 1.13% | 2.10% | 3.59% | Q1 2015 | Q4 2018 | 6 |
EW | EDWARDS LIFESCIENCES CORP | 4 | 1 | 0.11% | 2.00% | 3.52% | Q4 2014 | Q2 2022 | 6 |
CNC | CENTENE CORP DEL | 3 | 1 | 0.85% | 1.98% | 3.19% | Q1 2016 | Q3 2018 | 6 |
IBB | ISHARES TR | 3 | 1 | 0.98% | 1.85% | 2.90% | Q4 2015 | Q1 2021 | 6 |
BMY | BRISTOL-MYERS SQUIBB CO | 5 | 1 | 0.27% | 1.73% | 2.70% | Q2 2015 | Q3 2020 | 6 |
SNN | SMITH & NEPHEW PLC | 4 | 2 | 1.10% | 1.62% | 2.16% | Q4 2014 | Q3 2019 | 6 |
SRPT | SAREPTA THERAPEUTICS INC | 4 | 1 | 0.25% | 1.20% | 2.04% | Q1 2016 | Q4 2020 | 6 |
VANECK VECTORS ETF TR | 3 | 1 | 0.22% | 1.07% | 1.60% | Q2 2021 | Q2 2023 | 6 | |
THERMO FISHER SCIENTIF... | 4 | 1 | 0.17% | 0.96% | 2.76% | Q2 2021 | Q2 2023 | 6 | |
BIIB | BIOGEN INC | 4 | 1 | 0.08% | 0.93% | 1.51% | Q2 2015 | Q4 2022 | 6 |
ABBOTT LABS | 4 | 2 | 0.36% | 0.92% | 1.32% | Q3 2021 | Q3 2023 | 6 | |
AXGN | AXOGEN INC | 5 | 1 | 0.08% | 0.85% | 1.42% | Q4 2016 | Q1 2019 | 6 |
STAAR SURGICAL CO | 3 | 1 | 0.44% | 0.79% | 1.51% | Q3 2021 | Q3 2023 | 6 | |
R1 RCM INC | 6 | 6 | 0.25% | 0.69% | 1.46% | Q2 2022 | Q3 2023 | 6 | |
SIBN | SI BONE INC | 5 | 1 | 0.50% | 0.67% | 0.90% | Q4 2018 | Q1 2021 | 6 |
ESTABLISHMENT LABS HLD... | 2 | 1 | 0.08% | 0.61% | 2.07% | Q2 2021 | Q3 2023 | 6 | |
PROF | PROFOUND MED CORP | 6 | 6 | 0.33% | 0.60% | 0.93% | Q1 2020 | Q2 2021 | 6 |
10X GENOMICS INC | 6 | 6 | 0.16% | 0.60% | 0.96% | Q2 2021 | Q3 2022 | 6 | |
DEXCOM INC | 3 | 1 | 0.21% | 0.59% | 1.01% | Q2 2021 | Q3 2023 | 6 | |
NEURODERM LTD | 5 | 1 | 0.17% | 0.54% | 0.83% | Q2 2015 | Q2 2017 | 6 | |
SOMALOGIC INC | 5 | 1 | 0.15% | 0.53% | 1.05% | Q3 2021 | Q1 2023 | 6 | |
INMODE LTD | 4 | 2 | 0.10% | 0.48% | 1.15% | Q1 2022 | Q3 2023 | 6 | |
FOLD | AMICUS THERAPEUTICS INC | 3 | 1 | 0.18% | 0.48% | 0.88% | Q1 2016 | Q1 2021 | 6 |
MEDPACE HLDGS INC | 5 | 1 | 0.16% | 0.48% | 0.90% | Q3 2021 | Q2 2023 | 6 | |
ARNA | ARENA PHARMACEUTICALS INC | 4 | 2 | 0.04% | 0.46% | 1.17% | Q2 2017 | Q4 2021 | 6 |
HOLOGIC INC | 3 | 1 | 0.16% | 0.46% | 1.12% | Q2 2021 | Q3 2023 | 6 | |
TNXP | TONIX PHARMACEUTICALS ... | 6 | 6 | 0.18% | 0.45% | 0.70% | Q1 2015 | Q2 2016 | 6 |
SPDR SER TR | 6 | 6 | 0.38% | 0.45% | 0.58% | Q3 2021 | Q4 2022 | 6 | |
VRAY | VIEWRAY INC | 6 | 6 | 0.13% | 0.42% | 1.12% | Q2 2018 | Q3 2019 | 6 |
NANOSTRING TECHNOLOGIE... | 3 | 1 | 0.18% | 0.42% | 1.03% | Q2 2021 | Q3 2023 | 6 | |
TNDM | TANDEM DIABETES CARE INC | 5 | 1 | 0.10% | 0.41% | 0.74% | Q3 2018 | Q3 2022 | 6 |
INTEGRA LIFESCIENCES H... | 4 | 1 | 0.26% | 0.39% | 0.58% | Q3 2021 | Q2 2023 | 6 | |
IVERIC BIO INC | 6 | 6 | 0.14% | 0.34% | 0.65% | Q3 2021 | Q4 2022 | 6 | |
ATAI | ATAI LIFE SCIENCES NV | 6 | 6 | 0.14% | 0.32% | 0.72% | Q2 2021 | Q3 2022 | 6 |
KALA | KALA PHARMACEUTICALS INC | 5 | 1 | 0.17% | 0.31% | 0.61% | Q1 2018 | Q4 2019 | 6 |
EVH | EVOLENT HEALTH INC | 3 | 1 | 0.16% | 0.30% | 0.60% | Q3 2021 | Q2 2023 | 6 |
PRVA | PRIVIA HEALTH GROUP INC | 6 | 6 | 0.21% | 0.29% | 0.48% | Q2 2021 | Q3 2022 | 6 |
CYTEK BIOSCIENCES INC | 6 | 6 | 0.15% | 0.28% | 0.45% | Q3 2021 | Q4 2022 | 6 | |
AGL | AGILON HEALTH INC | 6 | 6 | 0.04% | 0.27% | 0.48% | Q2 2021 | Q3 2022 | 6 |
BHVN | BIOHAVEN PHARMACTL HLD... | 2 | 1 | 0.04% | 0.26% | 0.49% | Q4 2017 | Q1 2022 | 6 |
FOLD | AMICUS THERAPEUTICS INC | 4 | 1 | 0.01% | 0.22% | 0.89% | Q1 2018 | Q1 2021 | 6 |
ITEK | INOTEK PHARMACEUTICALS... | 5 | 1 | 0.13% | 0.22% | 0.32% | Q1 2015 | Q3 2016 | 6 |
STML | STEMLINE THERAPEUTICS INC | 3 | 3 | 0.07% | 0.20% | 0.36% | Q1 2017 | Q3 2019 | 6 |
AGRX | AGILE THERAPEUTICS INC | 5 | 1 | 0.02% | 0.20% | 0.38% | Q3 2016 | Q1 2019 | 6 |
HZNP | HORIZON THERAPEUTICS P... | 3 | 1 | 0.05% | 0.13% | 0.36% | Q1 2020 | Q4 2022 | 6 |
ARQT | ARCUTIS BIOTHERAPEUTIC... | 6 | 6 | 0.08% | 0.11% | 0.12% | Q1 2021 | Q2 2022 | 6 |
TVTX | TRAVERE THERAPEUTICS INC | 6 | 6 | 0.04% | 0.10% | 0.23% | Q1 2021 | Q2 2022 | 6 |
MRTX | MIRATI THERAPEUTICS INC | 5 | 1 | 0.03% | 0.10% | 0.20% | Q4 2020 | Q3 2022 | 6 |
IMGN | IMMUNOGEN INC | 5 | 1 | 0.01% | 0.10% | 0.19% | Q4 2020 | Q4 2022 | 6 |
LQDA | LIQUIDIA TECHNOLOGIES INC | 2 | 2 | 0.01% | 0.08% | 0.17% | Q2 2020 | Q4 2022 | 6 |
VRDN | VIRIDIAN THERAPEUTICS INC | 6 | 6 | 0.03% | 0.06% | 0.09% | Q3 2021 | Q4 2022 | 6 |
CYCC | CYCLACEL PHARMACEUTICA... | 6 | 6 | 0.01% | 0.04% | 0.14% | Q4 2020 | Q1 2022 | 6 |
IVERIC BIO INC | 6 | 6 | 0.01% | 0.02% | 0.04% | Q3 2021 | Q4 2022 | 6 | |
SSPKW | SILVER SPIKE ACQUISITI... | 6 | 6 | 0.00% | 0.00% | 0.01% | Q4 2019 | Q1 2021 | 6 |
AGN | ALLERGAN PLC | 4 | 1 | 0.99% | 4.32% | 10.36% | Q1 2016 | Q1 2018 | 5 |
EVHC | ENVISION HEALTHCARE CORP | 5 | 5 | 1.30% | 2.68% | 4.66% | Q4 2016 | Q4 2017 | 5 |
SYK | STRYKER CORP | 3 | 2 | 0.88% | 2.51% | 4.03% | Q2 2015 | Q3 2016 | 5 |
HOLX | HOLOGIC INC | 2 | 1 | 0.32% | 1.93% | 3.18% | Q4 2016 | Q3 2023 | 5 |
MDT | MEDTRONIC PLC | 4 | 1 | 1.27% | 1.92% | 2.95% | Q2 2016 | Q3 2018 | 5 |
SNN | SMITH & NEPHEW PLC | 3 | 1 | 0.99% | 1.83% | 3.00% | Q4 2014 | Q3 2019 | 5 |
OMI | OWENS & MINOR INC NEW | 5 | 5 | 1.28% | 1.82% | 2.22% | Q2 2015 | Q2 2016 | 5 |
BMY | BRISTOL-MYERS SQUIBB CO | 2 | 1 | 0.31% | 1.66% | 3.74% | Q3 2017 | Q3 2020 | 5 |
SELECT SECTOR SPDR TR | 3 | 1 | 0.29% | 1.64% | 3.15% | Q2 2021 | Q2 2023 | 5 | |
ALIM | ALIMERA SCIENCES INC | 5 | 5 | 0.06% | 1.62% | 3.07% | Q4 2014 | Q4 2015 | 5 |
SPNC | SPECTRANETICS CORP | 4 | 1 | 0.76% | 1.58% | 2.19% | Q2 2015 | Q3 2016 | 5 |
AMGN | AMGEN INC | 3 | 2 | 0.78% | 1.56% | 2.20% | Q1 2016 | Q4 2018 | 5 |
CYNA | CYNAPSUS THERAPEUTICS INC | 5 | 5 | 1.07% | 1.43% | 1.77% | Q2 2015 | Q2 2016 | 5 |
QGEN | QIAGEN NV | 3 | 2 | 0.92% | 1.40% | 2.09% | Q2 2015 | Q2 2017 | 5 |
MEDTRONIC PLC | 3 | 1 | 0.52% | 1.27% | 1.93% | Q2 2021 | Q4 2022 | 5 | |
ELGX | ENDOLOGIX INC | 4 | 1 | 1.05% | 1.27% | 1.66% | Q3 2015 | Q4 2016 | 5 |
ABMD | ABIOMED INC | 4 | 1 | 0.25% | 1.18% | 2.66% | Q2 2019 | Q3 2020 | 5 |
INSP | INSPIRE MED SYS INC | 3 | 1 | 0.43% | 1.18% | 2.87% | Q4 2018 | Q3 2020 | 5 |
QGEN | QIAGEN NV | 2 | 1 | 0.32% | 1.08% | 1.76% | Q3 2017 | Q4 2019 | 5 |
BMRN | BIOMARIN PHARMACEUTICA... | 2 | 1 | 0.04% | 0.95% | 2.09% | Q4 2017 | Q1 2022 | 5 |
DANAHER CORPORATION | 3 | 1 | 0.32% | 0.90% | 2.15% | Q2 2021 | Q2 2023 | 5 | |
REGN | REGENERON PHARMACEUTICALS | 2 | 1 | 0.17% | 0.89% | 1.90% | Q4 2017 | Q2 2021 | 5 |
NVRO | NEVRO CORP | 3 | 1 | 0.28% | 0.89% | 1.92% | Q2 2018 | Q4 2020 | 5 |
VNDA | VANDA PHARMACEUTICALS INC | 4 | 1 | 0.26% | 0.88% | 1.93% | Q4 2014 | Q1 2016 | 5 |
GUARDANT HEALTH INC | 5 | 5 | 0.07% | 0.82% | 1.78% | Q4 2021 | Q4 2022 | 5 | |
IDEXX LABS INC | 3 | 2 | 0.31% | 0.75% | 1.73% | Q3 2021 | Q4 2022 | 5 | |
CSII | CARDIOVASCULAR SYS INC... | 1 | 1 | 0.01% | 0.68% | 1.33% | Q4 2014 | Q1 2022 | 5 |
RIGL | RIGEL PHARMACEUTICALS INC | 5 | 5 | 0.15% | 0.64% | 1.22% | Q4 2017 | Q4 2018 | 5 |
FLKS | FLEX PHARMA INC | 5 | 5 | 0.49% | 0.61% | 0.75% | Q3 2015 | Q3 2016 | 5 |
IRTC | IRHYTHM TECHNOLOGIES INC | 3 | 2 | 0.20% | 0.61% | 1.20% | Q1 2019 | Q4 2020 | 5 |
STAA | STAAR SURGICAL CO | 3 | 1 | 0.22% | 0.56% | 1.02% | Q1 2015 | Q3 2019 | 5 |
SRPT | SAREPTA THERAPEUTICS INC | 2 | 1 | 0.06% | 0.54% | 0.85% | Q3 2016 | Q1 2022 | 5 |
CELLDEX THERAPEUTICS I... | 5 | 5 | 0.32% | 0.54% | 0.93% | Q4 2021 | Q4 2022 | 5 | |
VIVE | VIVEVE MED INC | 5 | 5 | 0.30% | 0.51% | 0.69% | Q2 2016 | Q2 2017 | 5 |
NEOVASC INC | 2 | 1 | 0.06% | 0.51% | 1.44% | Q4 2014 | Q1 2017 | 5 | |
APELLIS PHARMACEUTICAL... | 4 | 1 | 0.26% | 0.49% | 0.79% | Q3 2021 | Q4 2022 | 5 | |
PACIFIC BIOSCIENCES CA... | 5 | 5 | 0.40% | 0.47% | 0.57% | Q3 2021 | Q3 2022 | 5 | |
TFX | TELEFLEX INCORPORATED | 3 | 1 | 0.22% | 0.47% | 1.07% | Q1 2016 | Q1 2021 | 5 |
BDSI | BIODELIVERY SCIENCES I... | 4 | 1 | 0.37% | 0.45% | 0.53% | Q3 2015 | Q3 2019 | 5 |
NTLA | INTELLIA THERAPEUTICS INC | 5 | 5 | 0.17% | 0.43% | 1.08% | Q1 2021 | Q1 2022 | 5 |
DERMTECH INC | 5 | 5 | 0.25% | 0.42% | 0.60% | Q1 2020 | Q1 2021 | 5 | |
IRHYTHM TECHNOLOGIES INC | 4 | 1 | 0.09% | 0.37% | 0.50% | Q2 2021 | Q4 2022 | 5 | |
TELEFLEX INCORPORATED | 2 | 1 | 0.23% | 0.36% | 0.48% | Q3 2021 | Q2 2023 | 5 | |
EXACT SCIENCES CORP | 5 | 5 | 0.19% | 0.34% | 0.68% | Q2 2021 | Q2 2022 | 5 | |
ADMA | ADMA BIOLOGICS INC | 3 | 1 | 0.02% | 0.30% | 0.75% | Q2 2016 | Q4 2022 | 5 |
NVRO | NEVRO CORP | 2 | 1 | 0.04% | 0.29% | 0.81% | Q4 2014 | Q3 2021 | 5 |
ESPR | ESPERION THERAPEUTICS ... | 3 | 2 | 0.08% | 0.28% | 0.96% | Q4 2014 | Q4 2022 | 5 |
DCPH | DECIPHERA PHARMACEUTIC... | 2 | 1 | 0.04% | 0.27% | 0.65% | Q3 2017 | Q4 2021 | 5 |
CHRS | COHERUS BIOSCIENCES INC | 4 | 1 | 0.09% | 0.27% | 0.38% | Q4 2017 | Q3 2019 | 5 |
ORTHOPEDIATRICS CORP | 4 | 1 | 0.10% | 0.27% | 0.40% | Q3 2021 | Q3 2023 | 5 | |
TKNO | ALPHA TEKNOVA INC | 5 | 5 | 0.11% | 0.19% | 0.26% | Q2 2021 | Q2 2022 | 5 |
TPB | TURNING PT BRANDS INC | 5 | 5 | 0.05% | 0.18% | 0.32% | Q3 2020 | Q3 2021 | 5 |
LHDX | LUCIRA HEALTH INC | 5 | 5 | 0.08% | 0.17% | 0.36% | Q2 2021 | Q2 2022 | 5 |
ARVN | ARVINAS INC | 3 | 1 | 0.06% | 0.15% | 0.27% | Q3 2018 | Q2 2021 | 5 |
ITCI | INTRA-CELLULAR THERAPI... | 1 | 1 | 0.06% | 0.14% | 0.20% | Q2 2018 | Q3 2021 | 5 |
NEKTAR THERAPEUTICS | 5 | 5 | 0.01% | 0.11% | 0.26% | Q3 2021 | Q3 2022 | 5 | |
ATHA | ATHIRA PHARMA INC | 5 | 5 | 0.01% | 0.09% | 0.22% | Q4 2021 | Q4 2022 | 5 |
XENE | XENON PHARMACEUTICALS INC | 4 | 1 | 0.02% | 0.09% | 0.28% | Q2 2018 | Q2 2022 | 5 |
KDNY | CHINOOK THERAPEUTICS INC | 4 | 1 | 0.03% | 0.06% | 0.12% | Q2 2021 | Q4 2022 | 5 |
PSTX | POSEIDA THERAPEUTICS INC | 4 | 1 | 0.02% | 0.04% | 0.07% | Q3 2020 | Q4 2021 | 5 |
LOGC | LOGICBIO THERAPEUTICS INC | 5 | 5 | 0.02% | 0.04% | 0.07% | Q4 2020 | Q4 2021 | 5 |
RENOVACOR INC | 5 | 5 | 0.01% | 0.03% | 0.04% | Q3 2021 | Q3 2022 | 5 | |
ROIVANT SCIENCES LTD | 5 | 5 | 0.01% | 0.01% | 0.02% | Q4 2021 | Q4 2022 | 5 | |
TCACU | TUATARA CAPITAL ACQUIS... | 5 | 5 | 0.01% | 0.01% | 0.01% | Q1 2021 | Q1 2022 | 5 |
RENOVACOR INC | 5 | 5 | 0.00% | 0.00% | 0.00% | Q3 2021 | Q3 2022 | 5 | |
SPRINGBIG HOLDINGS INC | 5 | 5 | 0.00% | 0.00% | 0.00% | Q2 2022 | Q2 2023 | 5 | |
QQQ | INVESCO QQQ TR | 3 | 1 | 1.53% | 7.19% | 11.72% | Q1 2020 | Q1 2021 | 4 |
LIVN | LIVANOVA PLC | 2 | 1 | 0.47% | 4.51% | 7.80% | Q4 2017 | Q2 2020 | 4 |
ILMN | ILLUMINA INC | 2 | 1 | 0.54% | 4.30% | 13.58% | Q4 2014 | Q4 2020 | 4 |
CI | CIGNA CORPORATION | 4 | 4 | 2.60% | 3.91% | 4.79% | Q1 2015 | Q4 2015 | 4 |
SYK | STRYKER CORPORATION | 2 | 1 | 1.40% | 3.22% | 6.94% | Q4 2014 | Q2 2019 | 4 |
TFX | TELEFLEX INC | 4 | 4 | 2.49% | 3.07% | 3.54% | Q1 2015 | Q4 2015 | 4 |
AET | AETNA INC NEW | 4 | 4 | 1.77% | 2.57% | 4.02% | Q1 2016 | Q4 2016 | 4 |
MJ | ETF MANAGERS TR | 4 | 4 | 2.04% | 2.30% | 2.60% | Q4 2018 | Q3 2019 | 4 |
BIO | BIO RAD LABS INC | 4 | 4 | 1.82% | 2.26% | 3.12% | Q4 2016 | Q3 2017 | 4 |
SHPG | SHIRE PLC | 3 | 1 | 1.82% | 2.10% | 2.35% | Q1 2016 | Q1 2017 | 4 |
XRAY | DENTSPLY SIRONA INC | 2 | 1 | 1.00% | 1.96% | 2.80% | Q4 2016 | Q1 2019 | 4 |
VRX | VALEANT PHARMACEUTICAL... | 4 | 4 | 1.26% | 1.88% | 2.35% | Q4 2014 | Q3 2015 | 4 |
CYBX | CYBERONICS INC | 4 | 4 | 1.00% | 1.74% | 2.08% | Q4 2014 | Q3 2015 | 4 |
EVHC | ENVISION HEALTHCARE HL... | 4 | 4 | 0.88% | 1.71% | 2.26% | Q4 2015 | Q3 2016 | 4 |
ADVISORSHARES TR | 2 | 2 | 0.81% | 1.66% | 3.75% | Q3 2022 | Q3 2023 | 4 | |
SYK | STRYKER CORPORATION | 3 | 1 | 0.54% | 1.50% | 2.65% | Q4 2016 | Q4 2020 | 4 |
BHVN | BIOHAVEN PHARMACTL HLD... | 3 | 1 | 0.23% | 1.48% | 2.14% | Q2 2019 | Q4 2020 | 4 |
ISRG | INTUITIVE SURGICAL INC | 3 | 1 | 1.22% | 1.47% | 1.86% | Q1 2015 | Q4 2017 | 4 |
HUM | HUMANA INC | 1 | 1 | 0.17% | 1.42% | 2.53% | Q1 2015 | Q3 2023 | 4 |
MEDP | MEDPACE HLDGS INC | 3 | 1 | 1.06% | 1.28% | 1.44% | Q3 2016 | Q4 2017 | 4 |
AFFX | AFFYMETRIX INC | 4 | 4 | 0.84% | 1.25% | 1.68% | Q1 2015 | Q4 2015 | 4 |
CELG | CELGENE CORP | 2 | 1 | 0.67% | 1.23% | 1.76% | Q1 2016 | Q1 2019 | 4 |
WMGIZ | WRIGHT MEDICAL GROUP R... | 4 | 4 | 0.96% | 1.20% | 1.51% | Q4 2014 | Q3 2015 | 4 |
AVXS | AVEXIS INC | 4 | 4 | 0.82% | 1.19% | 1.63% | Q2 2016 | Q1 2017 | 4 |
DXCM | DEXCOM INC | 1 | 1 | 0.25% | 1.14% | 2.02% | Q4 2014 | Q1 2019 | 4 |
HRC | HILL ROM HLDGS INC | 2 | 2 | 0.84% | 1.07% | 1.52% | Q4 2014 | Q3 2016 | 4 |
BAXTER INTL INC | 2 | 1 | 0.58% | 1.05% | 2.37% | Q3 2021 | Q2 2023 | 4 | |
SAREPTA THERAPEUTICS INC | 4 | 4 | 0.51% | 1.00% | 1.34% | Q1 2022 | Q4 2022 | 4 | |
DXCM | DEXCOM INC | 3 | 1 | 0.67% | 0.91% | 1.37% | Q4 2017 | Q1 2021 | 4 |
TRXC | TRANSENTERIX INC | 4 | 4 | 0.40% | 0.89% | 1.28% | Q1 2015 | Q4 2015 | 4 |
GWPH | GW PHARMACEUTICALS PLC | 2 | 1 | 0.33% | 0.84% | 1.32% | Q3 2016 | Q3 2019 | 4 |
CLVS | CLOVIS ONCOLOGY INC | 2 | 1 | 0.02% | 0.82% | 2.60% | Q1 2017 | Q2 2021 | 4 |
VAR | VARIAN MED SYS INC | 1 | 1 | 0.59% | 0.82% | 1.16% | Q2 2016 | Q1 2020 | 4 |
ILLUMINA INC | 2 | 1 | 0.60% | 0.80% | 0.94% | Q1 2022 | Q2 2023 | 4 | |
BRKS | BROOKS AUTOMATION INC NEW | 1 | 1 | 0.38% | 0.75% | 1.20% | Q3 2017 | Q4 2022 | 4 |
OFIX | ORTHOFIX MED INC | 4 | 4 | 0.13% | 0.71% | 1.11% | Q3 2018 | Q2 2019 | 4 |
PPH | VANECK VECTORS PHARMAC... | 3 | 1 | 0.32% | 0.69% | 1.08% | Q2 2019 | Q1 2021 | 4 |
HYFM | HYDROFARM HLDGS GROUP INC | 4 | 4 | 0.49% | 0.67% | 0.77% | Q4 2020 | Q3 2021 | 4 |
SPPI | SPECTRUM PHARMACEUTICA... | 2 | 2 | 0.35% | 0.64% | 0.84% | Q2 2018 | Q3 2019 | 4 |
GUARDANT HEALTH INC | 3 | 1 | 0.16% | 0.59% | 1.25% | Q3 2021 | Q3 2022 | 4 | |
HCA HEALTHCARE INC | 3 | 1 | 0.16% | 0.58% | 1.19% | Q2 2021 | Q2 2022 | 4 | |
ALCON AG | 2 | 1 | 0.34% | 0.57% | 0.88% | Q3 2021 | Q2 2023 | 4 | |
SEER | SEER INC | 4 | 4 | 0.26% | 0.53% | 0.90% | Q4 2020 | Q3 2021 | 4 |
ORGO | ORGANOGENESIS HLDGS INC | 3 | 1 | 0.18% | 0.53% | 0.78% | Q4 2020 | Q3 2023 | 4 |
ARRY | ARRAY BIOPHARMA INC | 4 | 4 | 0.06% | 0.51% | 0.88% | Q3 2016 | Q2 2017 | 4 |
EXACT SCIENCES CORP | 4 | 4 | 0.31% | 0.51% | 0.70% | Q1 2022 | Q4 2022 | 4 | |
AVNS | AVANOS MED INC | 4 | 4 | 0.29% | 0.49% | 0.58% | Q3 2018 | Q2 2019 | 4 |
PRIVIA HEALTH GROUP INC | 4 | 4 | 0.26% | 0.49% | 0.89% | Q1 2022 | Q4 2022 | 4 | |
NXTM | NXSTAGE MEDICAL INC | 2 | 1 | 0.10% | 0.48% | 0.74% | Q2 2015 | Q4 2016 | 4 |
QGEN | QIAGEN NV | 2 | 1 | 0.03% | 0.46% | 1.43% | Q1 2018 | Q4 2022 | 4 |
AGILENT TECHNOLOGIES INC | 2 | 1 | 0.23% | 0.43% | 0.74% | Q1 2022 | Q3 2023 | 4 | |
PTCT | PTC THERAPEUTICS INC | 3 | 1 | 0.23% | 0.42% | 0.60% | Q1 2015 | Q3 2017 | 4 |
CONMED CORP | 2 | 1 | 0.25% | 0.40% | 0.56% | Q4 2021 | Q3 2023 | 4 | |
TANDEM DIABETES CARE INC | 2 | 1 | 0.32% | 0.39% | 0.55% | Q3 2021 | Q3 2023 | 4 | |
TELADOC HEALTH INC | 2 | 1 | 0.12% | 0.39% | 0.85% | Q2 2021 | Q3 2022 | 4 | |
SKIN | THE BEAUTY HEALTH COMPANY | 3 | 1 | 0.23% | 0.38% | 0.55% | Q2 2021 | Q2 2022 | 4 |
UNIVERSAL HLTH SVCS INC | 4 | 4 | 0.12% | 0.38% | 0.80% | Q2 2021 | Q1 2022 | 4 | |
RCKT | ROCKET PHARMACEUTICALS... | 2 | 1 | 0.05% | 0.37% | 0.79% | Q1 2018 | Q3 2022 | 4 |
SILK | SILK RD MED INC | 3 | 1 | 0.22% | 0.36% | 0.48% | Q2 2019 | Q4 2020 | 4 |
MDXG | MIMEDX GROUP INC | 4 | 4 | 0.24% | 0.34% | 0.46% | Q4 2020 | Q3 2021 | 4 |
AZN | ASTRAZENECA PLC | 3 | 1 | 0.06% | 0.33% | 0.62% | Q3 2021 | Q3 2022 | 4 |
IRTC | IRHYTHM TECHNOLOGIES INC | 2 | 2 | 0.23% | 0.29% | 0.34% | Q2 2021 | Q3 2022 | 4 |
AVTR | AVANTOR INC | 1 | 1 | 0.04% | 0.29% | 0.72% | Q2 2019 | Q4 2022 | 4 |
EVAR | LOMBARD MED INC | 4 | 4 | 0.11% | 0.28% | 0.80% | Q4 2014 | Q3 2015 | 4 |
NARI | INARI MED INC | 4 | 4 | 0.24% | 0.27% | 0.30% | Q2 2020 | Q1 2021 | 4 |
KONINKLIJKE PHILIPS N V | 3 | 1 | 0.20% | 0.26% | 0.36% | Q3 2021 | Q4 2022 | 4 | |
ITCI | INTRA CELLULAR THERAPI... | 3 | 1 | 0.06% | 0.24% | 0.59% | Q2 2018 | Q2 2019 | 4 |
ITMR | ITAMAR MED LTD | 3 | 1 | 0.16% | 0.22% | 0.32% | Q1 2020 | Q1 2021 | 4 |
EOLS | EVOLUS INC | 2 | 1 | 0.02% | 0.21% | 0.55% | Q1 2018 | Q4 2022 | 4 |
REPLIGEN CORP | 3 | 1 | 0.11% | 0.21% | 0.32% | Q3 2021 | Q4 2022 | 4 | |
CORTEXYME INC | 2 | 2 | 0.03% | 0.20% | 0.58% | Q2 2021 | Q2 2022 | 4 | |
BNGO | BIONANO GENOMICS INC | 4 | 4 | 0.08% | 0.19% | 0.24% | Q4 2020 | Q3 2021 | 4 |
CMPS | COMPASS PATHWAYS PLC | 4 | 4 | 0.11% | 0.18% | 0.23% | Q3 2020 | Q2 2021 | 4 |
CBAY | CYMABAY THERAPEUTICS INC | 4 | 4 | 0.04% | 0.18% | 0.31% | Q2 2015 | Q1 2016 | 4 |
AUPH | AURINIA PHARMACEUTICAL... | 2 | 1 | 0.02% | 0.18% | 0.48% | Q4 2019 | Q1 2021 | 4 |
ARYD | ARYA SCIENCES ACQU COR... | 4 | 4 | 0.16% | 0.17% | 0.18% | Q1 2021 | Q4 2021 | 4 |
ADAPTIVE BIOTECHNOLOGI... | 2 | 1 | 0.04% | 0.16% | 0.30% | Q3 2021 | Q2 2023 | 4 | |
RACB | RESEARCH ALLIANCE CORP II | 4 | 4 | 0.15% | 0.16% | 0.18% | Q1 2021 | Q4 2021 | 4 |
GERON CORP | 4 | 4 | 0.03% | 0.16% | 0.23% | Q1 2022 | Q4 2022 | 4 | |
TRILLIUM THERAPEUTICS INC | 4 | 4 | 0.05% | 0.12% | 0.23% | Q1 2020 | Q4 2020 | 4 | |
ANAVEX LIFE SCIENCES CORP | 4 | 4 | 0.08% | 0.11% | 0.14% | Q1 2022 | Q4 2022 | 4 | |
APEN | APOLLO ENDOSURGERY INC | 4 | 4 | 0.08% | 0.11% | 0.14% | Q4 2021 | Q3 2022 | 4 |
QURE | UNIQURE NV | 2 | 1 | 0.06% | 0.09% | 0.11% | Q1 2019 | Q2 2020 | 4 |
BLU | BELLUS HEALTH INC NEW | 4 | 4 | 0.06% | 0.08% | 0.11% | Q3 2021 | Q2 2022 | 4 |
AGTC | APPLIED GENETIC TECHNO... | 3 | 1 | 0.03% | 0.06% | 0.10% | Q1 2020 | Q1 2021 | 4 |
VSTM | VERASTEM INC | 3 | 1 | 0.02% | 0.06% | 0.08% | Q2 2020 | Q4 2022 | 4 |
ABGI | ABG ACQUISITION CORP I | 4 | 4 | 0.04% | 0.05% | 0.07% | Q1 2021 | Q4 2021 | 4 |
PMGMU | PRIVETERRA ACQUISITION... | 4 | 4 | 0.05% | 0.05% | 0.06% | Q1 2021 | Q4 2021 | 4 |
SPKBU | SILVER SPIKE ACQUISITN... | 4 | 4 | 0.02% | 0.05% | 0.14% | Q1 2021 | Q4 2021 | 4 |
EPIX | ESSA PHARMA INC | 4 | 4 | 0.01% | 0.05% | 0.11% | Q3 2020 | Q2 2021 | 4 |
EOLS | EVOLUS INC | 4 | 4 | 0.02% | 0.05% | 0.07% | Q1 2020 | Q4 2020 | 4 |
NGM | NGM BIOPHARMACEUTICALS... | 2 | 2 | 0.02% | 0.04% | 0.10% | Q3 2021 | Q4 2022 | 4 |
CYCN | CYCLERION THERAPEUTICS... | 4 | 4 | 0.03% | 0.04% | 0.06% | Q2 2021 | Q1 2022 | 4 |
NAUT | NAUTILUS BIOTECHNOLOGY... | 4 | 4 | 0.03% | 0.04% | 0.06% | Q2 2021 | Q1 2022 | 4 |
UPC | UNIVERSE PHARMACEUTICA... | 4 | 4 | 0.01% | 0.03% | 0.07% | Q3 2021 | Q2 2022 | 4 |
TRAVERE THERAPEUTICS INC | 4 | 4 | 0.02% | 0.02% | 0.03% | Q1 2022 | Q4 2022 | 4 | |
TCDA | TRICIDA INC | 2 | 2 | 0.01% | 0.02% | 0.05% | Q2 2021 | Q2 2022 | 4 |
CTMX | CYTOMX THERAPEUTICS INC | 4 | 4 | 0.02% | 0.02% | 0.04% | Q1 2021 | Q4 2021 | 4 |
HSGX | HISTOGENICS CORP | 4 | 4 | 0.01% | 0.02% | 0.04% | Q3 2016 | Q2 2017 | 4 |
BAX | BAXTER INTL INC | 1 | 1 | 1.51% | 3.99% | 8.84% | Q1 2015 | Q4 2019 | 3 |
MRK | MERCK & CO. INC | 1 | 1 | 0.22% | 3.07% | 6.44% | Q2 2017 | Q1 2021 | 3 |
ESRX | EXPRESS SCRIPTS HLDG CO | 3 | 3 | 0.94% | 2.41% | 4.43% | Q2 2017 | Q4 2017 | 3 |
BCR | BARD C R INC | 2 | 1 | 1.06% | 2.28% | 3.01% | Q3 2015 | Q1 2017 | 3 |
BDX | BECTON DICKINSON & CO | 1 | 1 | 1.79% | 2.15% | 2.70% | Q4 2014 | Q2 2016 | 3 |
GSK | GLAXOSMITHKLINE PLC | 2 | 1 | 1.83% | 2.08% | 2.44% | Q2 2016 | Q1 2017 | 3 |
INCY | INCYTE CORP | 3 | 3 | 1.71% | 2.05% | 2.46% | Q3 2017 | Q1 2018 | 3 |
EXAS | EXACT SCIENCES CORP | 2 | 1 | 1.62% | 1.94% | 2.44% | Q4 2014 | Q2 2017 | 3 |
T107PS | WRIGHT MEDICAL GROUP INC | 2 | 1 | 1.14% | 1.75% | 2.52% | Q4 2014 | Q3 2015 | 3 |
KTWO | K2M GROUP HLDGS INC | 3 | 3 | 1.23% | 1.68% | 2.03% | Q3 2016 | Q1 2017 | 3 |
ALXN | ALEXION PHARMACEUTICAL... | 3 | 3 | 0.59% | 1.64% | 2.20% | Q1 2020 | Q3 2020 | 3 |
AMGN | AMGEN INC | 1 | 1 | 0.52% | 1.61% | 3.31% | Q1 2018 | Q3 2020 | 3 |
HCA | HCA HOLDINGS INC | 1 | 1 | 0.29% | 1.60% | 3.22% | Q4 2015 | Q4 2019 | 3 |
MCK | MCKESSON CORP | 2 | 1 | 1.15% | 1.55% | 2.18% | Q4 2014 | Q2 2016 | 3 |
BRKR | BRUKER CORP | 1 | 1 | 0.76% | 1.47% | 2.72% | Q4 2015 | Q2 2019 | 3 |
UNITEDHEALTH GROUP INC | 2 | 1 | 1.01% | 1.47% | 1.75% | Q3 2021 | Q4 2022 | 3 | |
RESMED INC | 2 | 1 | 0.45% | 1.40% | 2.73% | Q1 2022 | Q3 2023 | 3 | |
EW | EDWARDS LIFESCIENCES CORP | 2 | 1 | 1.12% | 1.40% | 1.67% | Q4 2015 | Q3 2017 | 3 |
RCPT | RECEPTOS INC | 3 | 3 | 1.01% | 1.38% | 1.83% | Q4 2014 | Q2 2015 | 3 |
SIEN | SIENTRA INC | 2 | 1 | 0.24% | 1.37% | 2.87% | Q1 2018 | Q1 2019 | 3 |
ISRG | INTUITIVE SURGICAL INC | 2 | 1 | 0.14% | 1.32% | 3.60% | Q4 2014 | Q4 2022 | 3 |
CYNO | CYNOSURE INC | 3 | 3 | 0.93% | 1.28% | 1.67% | Q2 2016 | Q4 2016 | 3 |
SUPN | SUPERNUS PHARMACEUTICA... | 3 | 3 | 0.51% | 1.16% | 1.60% | Q4 2016 | Q2 2017 | 3 |
COO | COOPER COS INC | 1 | 1 | 0.48% | 1.13% | 1.49% | Q4 2014 | Q2 2020 | 3 |
ZIMMER BIOMET HOLDINGS... | 1 | 1 | 0.30% | 1.12% | 2.12% | Q1 2022 | Q3 2023 | 3 | |
HOLX | HOLOGIC INC | 1 | 1 | 0.21% | 1.08% | 2.23% | Q3 2015 | Q3 2020 | 3 |
LLY | LILLY ELI & CO | 1 | 1 | 0.56% | 1.05% | 1.99% | Q3 2016 | Q4 2020 | 3 |
SPNC | SPECTRANETICS CORP | 3 | 3 | 0.13% | 0.99% | 1.95% | Q2 2015 | Q4 2015 | 3 |
TEVA | TEVA PHARMACEUTICAL IN... | 2 | 1 | 0.67% | 0.98% | 1.18% | Q4 2014 | Q1 2017 | 3 |
TSRO | TESARO INC | 1 | 1 | 0.42% | 0.87% | 1.66% | Q2 2017 | Q3 2018 | 3 |
ILLUMINA INC | 2 | 1 | 0.64% | 0.86% | 1.01% | Q2 2021 | Q2 2022 | 3 | |
BOSTON SCIENTIFIC CORP | 2 | 1 | 0.58% | 0.84% | 1.25% | Q1 2022 | Q3 2023 | 3 | |
ATRC | ATRICURE INC | 1 | 1 | 0.09% | 0.83% | 2.25% | Q1 2020 | Q1 2021 | 3 |
ALGN | ALIGN TECHNOLOGY INC | 2 | 1 | 0.42% | 0.81% | 1.01% | Q4 2015 | Q1 2019 | 3 |
ABT | ABBOTT LABS | 1 | 1 | 0.51% | 0.79% | 1.05% | Q4 2019 | Q1 2021 | 3 |
OPHT | OPHTHOTECH CORP | 3 | 3 | 0.60% | 0.79% | 1.14% | Q1 2016 | Q3 2016 | 3 |
SYNH | SYNEOS HEALTH INC | 2 | 1 | 0.04% | 0.78% | 1.32% | Q2 2018 | Q2 2019 | 3 |
CI | CIGNA CORP NEW | 2 | 1 | 0.40% | 0.75% | 1.10% | Q4 2019 | Q1 2021 | 3 |
GKOS | GLAUKOS CORP | 1 | 1 | 0.26% | 0.75% | 1.24% | Q2 2018 | Q3 2020 | 3 |
VCEL | VERICEL CORP | 3 | 3 | 0.59% | 0.74% | 0.86% | Q3 2020 | Q1 2021 | 3 |
EWA | ISHARES | 2 | 1 | 0.66% | 0.73% | 0.80% | Q4 2015 | Q4 2016 | 3 |
AMRN | AMARIN CORP PLC | 2 | 1 | 0.25% | 0.72% | 1.23% | Q3 2018 | Q1 2020 | 3 |
INTELLIA THERAPEUTICS INC | 2 | 1 | 0.32% | 0.72% | 1.24% | Q2 2021 | Q3 2022 | 3 | |
WMGI | WRIGHT MED GROUP N V | 1 | 1 | 0.50% | 0.71% | 1.09% | Q2 2017 | Q3 2019 | 3 |
SPPI | SPECTRUM PHARMACEUTICA... | 2 | 1 | 0.07% | 0.71% | 1.10% | Q1 2018 | Q4 2019 | 3 |
INTELLIA THERAPEUTICS INC | 2 | 1 | 0.15% | 0.69% | 1.52% | Q2 2021 | Q2 2022 | 3 | |
ZGNX | ZOGENIX INC | 2 | 1 | 0.52% | 0.68% | 0.89% | Q3 2017 | Q3 2018 | 3 |
PERKINELMER INC | 1 | 1 | 0.51% | 0.68% | 0.91% | Q2 2021 | Q2 2022 | 3 | |
WATERS CORP | 2 | 1 | 0.52% | 0.67% | 0.95% | Q4 2021 | Q3 2023 | 3 | |
EW | EDWARDS LIFESCIENCES CORP | 2 | 1 | 0.21% | 0.67% | 1.36% | Q1 2019 | Q3 2020 | 3 |
VEEV | VEEVA SYSTEMS INC | 3 | 3 | 0.25% | 0.66% | 1.38% | Q2 2020 | Q4 2020 | 3 |
OMCL | OMNICELL COM | 1 | 1 | 0.57% | 0.66% | 0.76% | Q3 2018 | Q4 2019 | 3 |
CFMS | CONFORMIS INC | 1 | 1 | 0.10% | 0.66% | 1.24% | Q4 2016 | Q1 2021 | 3 |
NVTRQ | NUVECTRA CORP | 3 | 3 | 0.53% | 0.64% | 0.86% | Q1 2018 | Q3 2018 | 3 |
PPD | PPD INC | 2 | 1 | 0.35% | 0.64% | 1.14% | Q1 2020 | Q4 2020 | 3 |
IVC | INVACARE CORP | 2 | 1 | 0.51% | 0.64% | 0.75% | Q1 2016 | Q3 2019 | 3 |
CHRS | COHERUS BIOSCIENCES INC | 2 | 1 | 0.18% | 0.63% | 1.38% | Q4 2017 | Q3 2019 | 3 |
SAGE | SAGE THERAPEUTICS INC | 2 | 1 | 0.23% | 0.63% | 0.98% | Q2 2015 | Q1 2019 | 3 |
BECTON DICKINSON & CO | 2 | 1 | 0.41% | 0.63% | 0.97% | Q4 2021 | Q3 2022 | 3 | |
DGX | QUEST DIAGNOSTICS INC | 2 | 1 | 0.41% | 0.60% | 0.83% | Q4 2018 | Q4 2020 | 3 |
APR | APRIA INC | 3 | 3 | 0.40% | 0.54% | 0.61% | Q1 2021 | Q3 2021 | 3 |
SEER INC | 3 | 3 | 0.18% | 0.53% | 0.78% | Q4 2021 | Q2 2022 | 3 | |
MNTA | MOMENTA PHARMACEUTICAL... | 3 | 3 | 0.28% | 0.52% | 0.80% | Q4 2019 | Q2 2020 | 3 |
VAPO | VAPOTHERM INC | 3 | 3 | 0.47% | 0.52% | 0.60% | Q4 2018 | Q2 2019 | 3 |
PBYI | PUMA BIOTECHNOLOGY INC | 1 | 1 | 0.06% | 0.49% | 1.00% | Q3 2016 | Q1 2020 | 3 |
COLL | COLLEGIUM PHARMACEUTIC... | 1 | 1 | 0.36% | 0.48% | 0.60% | Q1 2017 | Q2 2018 | 3 |
VKTX | VIKING THERAPEUTICS INC | 3 | 3 | 0.18% | 0.46% | 0.74% | Q4 2017 | Q2 2018 | 3 |
ARQL | ARQULE INC | 3 | 3 | 0.04% | 0.45% | 1.06% | Q4 2018 | Q2 2019 | 3 |
TWST | TWIST BIOSCIENCE CORP | 3 | 3 | 0.22% | 0.44% | 0.63% | Q1 2020 | Q3 2020 | 3 |
EXAS | EXACT SCIENCES CORP | 1 | 1 | 0.11% | 0.44% | 0.80% | Q1 2019 | Q1 2021 | 3 |
CVS HEALTH CORP | 1 | 1 | 0.39% | 0.42% | 0.48% | Q3 2021 | Q4 2022 | 3 | |
PRQR | PROQR THRAPEUTICS N V | 3 | 3 | 0.23% | 0.42% | 0.79% | Q2 2018 | Q4 2018 | 3 |
OUTSET MED INC | 1 | 1 | 0.18% | 0.40% | 0.52% | Q2 2022 | Q3 2023 | 3 | |
ZGNX | ZOGENIX INC | 3 | 3 | 0.23% | 0.39% | 0.50% | Q1 2015 | Q3 2015 | 3 |
CNVY | CONVEY HLDG PARENT INC | 3 | 3 | 0.36% | 0.39% | 0.45% | Q3 2021 | Q1 2022 | 3 |
EXEL | EXELIXIS INC | 2 | 1 | 0.36% | 0.39% | 0.44% | Q3 2017 | Q4 2018 | 3 |
PULMONX CORP | 2 | 1 | 0.04% | 0.38% | 0.66% | Q4 2021 | Q4 2022 | 3 | |
OLINK HLDG AB | 3 | 3 | 0.27% | 0.38% | 0.52% | Q4 2021 | Q2 2022 | 3 | |
IMVT | IMMUNOVANT INC | 3 | 3 | 0.20% | 0.37% | 0.63% | Q2 2020 | Q4 2020 | 3 |
ALNYLAM PHARMACEUTICAL... | 2 | 1 | 0.06% | 0.36% | 0.80% | Q1 2022 | Q4 2022 | 3 | |
IMGN | IMMUNOGEN INC | 3 | 3 | 0.20% | 0.36% | 0.47% | Q3 2018 | Q1 2019 | 3 |
ALNYLAM PHARMACEUTICAL... | 2 | 1 | 0.26% | 0.35% | 0.42% | Q1 2022 | Q4 2022 | 3 | |
WALGREENS BOOTS ALLIAN... | 2 | 1 | 0.22% | 0.33% | 0.45% | Q3 2021 | Q3 2022 | 3 | |
TMDX | TRANSMEDICS GROUP INC | 3 | 3 | 0.29% | 0.33% | 0.42% | Q3 2022 | Q1 2023 | 3 |
TECH | BIO-TECHNE CORP | 2 | 1 | 0.29% | 0.31% | 0.35% | Q1 2022 | Q1 2023 | 3 |
HAE | HAEMONETICS CORP MASS | 2 | 1 | 0.25% | 0.29% | 0.36% | Q3 2020 | Q3 2021 | 3 |
SGYPQ | SYNERGY PHARMACEUTICAL... | 3 | 3 | 0.08% | 0.28% | 0.47% | Q1 2017 | Q3 2017 | 3 |
BCYC | BICYCLE THERAPEUTICS PLC | 3 | 3 | 0.18% | 0.28% | 0.36% | Q2 2022 | Q4 2022 | 3 |
RGEN | REPLIGEN CORP | 1 | 1 | 0.17% | 0.27% | 0.39% | Q4 2020 | Q3 2023 | 3 |
ZTS | 2 | 1 | 0.17% | 0.27% | 0.35% | Q2 2021 | Q1 2022 | 3 | |
LEMAITRE VASCULAR INC | 3 | 3 | 0.20% | 0.27% | 0.38% | Q3 2021 | Q1 2022 | 3 | |
QDEL | QUIDEL CORP | 2 | 1 | 0.11% | 0.26% | 0.36% | Q3 2017 | Q4 2020 | 3 |
GBT | GLOBAL BLOOD THERAPEUT... | 2 | 1 | 0.03% | 0.24% | 0.66% | Q1 2017 | Q2 2022 | 3 |
FOLD | AMICUS THERAPEUTICS INC | 3 | 3 | 0.03% | 0.24% | 0.47% | Q3 2020 | Q1 2021 | 3 |
NVAX | NOVAVAX INC | 3 | 3 | 0.12% | 0.23% | 0.29% | Q2 2019 | Q4 2019 | 3 |
AXSM | AXSOME THERAPEUTICS INC | 3 | 3 | 0.03% | 0.22% | 0.43% | Q1 2019 | Q3 2019 | 3 |
DNAY | CODEX DNA INC | 3 | 3 | 0.13% | 0.21% | 0.27% | Q2 2021 | Q4 2021 | 3 |
TG THERAPEUTICS INC | 3 | 3 | 0.09% | 0.21% | 0.36% | Q2 2022 | Q4 2022 | 3 | |
MRVI | MARAVAI LIFESCIENCES H... | 2 | 1 | 0.12% | 0.21% | 0.26% | Q4 2020 | Q3 2021 | 3 |
AKYA | AKOYA BIOSCIENCES INC | 1 | 1 | 0.10% | 0.20% | 0.35% | Q2 2021 | Q2 2023 | 3 |
SRACU | STABLE RD ACQUISITION ... | 3 | 3 | 0.07% | 0.18% | 0.40% | Q4 2019 | Q2 2020 | 3 |
CCCC | C4 THERAPEUTICS INC | 3 | 3 | 0.03% | 0.18% | 0.49% | Q3 2021 | Q1 2022 | 3 |
GINKGO BIOWORKS HOLDIN... | 3 | 3 | 0.11% | 0.18% | 0.24% | Q1 2022 | Q3 2022 | 3 | |
RDUS | RADIUS HEALTH INC | 1 | 1 | 0.03% | 0.18% | 0.32% | Q3 2016 | Q4 2021 | 3 |
CGEM | CULLINAN ONCOLOGY INC | 3 | 3 | 0.06% | 0.17% | 0.26% | Q1 2021 | Q3 2021 | 3 |
AXSM | AXSOME THERAPEUTICS INC | 2 | 1 | 0.04% | 0.14% | 0.32% | Q4 2018 | Q1 2020 | 3 |
CBYL | CARBYLAN THERAPEUTICS INC | 3 | 3 | 0.12% | 0.14% | 0.16% | Q2 2015 | Q4 2015 | 3 |
SCIENCE 37 HOLDINGS INC | 3 | 3 | 0.10% | 0.14% | 0.18% | Q1 2022 | Q3 2022 | 3 | |
CBIO | CATALYST BIOSCIENCES INC | 2 | 1 | 0.01% | 0.13% | 0.34% | Q4 2017 | Q4 2021 | 3 |
MTACU | MEDTECH ACQUISITION CORP | 3 | 3 | 0.03% | 0.13% | 0.29% | Q4 2020 | Q2 2021 | 3 |
AVITA MEDICAL INC | 3 | 3 | 0.12% | 0.13% | 0.14% | Q1 2022 | Q3 2022 | 3 | |
CBAY | CYMABAY THERAPEUTICS INC | 3 | 3 | 0.06% | 0.13% | 0.26% | Q3 2019 | Q1 2020 | 3 |
IMMUNOGEN INC | 3 | 3 | 0.09% | 0.13% | 0.19% | Q2 2021 | Q4 2021 | 3 | |
TRICIDA INC | 3 | 3 | 0.00% | 0.12% | 0.19% | Q2 2022 | Q4 2022 | 3 | |
BMYRT | BRISTOL-MYERS SQUIBB CO | 3 | 3 | 0.09% | 0.12% | 0.16% | Q1 2020 | Q3 2020 | 3 |
AURINIA PHARMACEUTICAL... | 3 | 3 | 0.06% | 0.10% | 0.14% | Q3 2021 | Q1 2022 | 3 | |
ZYME | ZYMEWORKS INC | 1 | 1 | 0.01% | 0.10% | 0.21% | Q3 2019 | Q2 2022 | 3 |
CHAQU | CHARDAN HEALTHCR ACQST... | 3 | 3 | 0.06% | 0.10% | 0.16% | Q2 2020 | Q4 2020 | 3 |
MRUS | MERUS N V | 2 | 1 | 0.06% | 0.09% | 0.16% | Q4 2021 | Q3 2022 | 3 |
FBRX | FORTE BIOSCIENCES INC | 3 | 3 | 0.07% | 0.09% | 0.11% | Q4 2020 | Q2 2021 | 3 |
QUOTIENT LTD | 3 | 3 | 0.02% | 0.09% | 0.16% | Q3 2021 | Q1 2022 | 3 | |
DECIPHERA PHARMACEUTIC... | 3 | 3 | 0.04% | 0.08% | 0.11% | Q2 2021 | Q4 2021 | 3 | |
ALKS | ALKERMES PLC | 2 | 1 | 0.06% | 0.08% | 0.10% | Q4 2019 | Q4 2022 | 3 |
VTGN | VISTAGEN THERAPEUTICS INC | 2 | 1 | 0.05% | 0.08% | 0.10% | Q1 2019 | Q4 2020 | 3 |
FRONU | FRONTIER ACQUISITION CORP | 3 | 3 | 0.06% | 0.07% | 0.08% | Q1 2021 | Q3 2021 | 3 |
FVAM | 5 01 ACQUISITION CORP | 3 | 3 | 0.06% | 0.07% | 0.08% | Q4 2020 | Q2 2021 | 3 |
CNCE | CONCERT PHARMACEUTICAL... | 1 | 1 | 0.01% | 0.07% | 0.14% | Q4 2020 | Q4 2022 | 3 |
BEAM | BEAM THERAPEUTICS INC | 3 | 3 | 0.04% | 0.07% | 0.10% | Q2 2021 | Q4 2021 | 3 |
STRYVE FOODS INC | 2 | 1 | 0.04% | 0.07% | 0.09% | Q3 2021 | Q2 2022 | 3 | |
COMPASS PATHWAYS PLC | 3 | 3 | 0.02% | 0.06% | 0.14% | Q2 2021 | Q4 2021 | 3 | |
CRVS | CORVUS PHARMACEUTICALS... | 3 | 3 | 0.03% | 0.06% | 0.11% | Q3 2021 | Q1 2022 | 3 |
DA32 LIFE SCNCE TEC AC... | 3 | 3 | 0.05% | 0.06% | 0.06% | Q3 2021 | Q1 2022 | 3 | |
ACRS | ACLARIS THERAPEUTICS INC | 2 | 1 | 0.01% | 0.05% | 0.13% | Q4 2020 | Q4 2021 | 3 |
GMTX | GEMINI THERAPEUTICS INC | 3 | 3 | 0.02% | 0.04% | 0.06% | Q3 2021 | Q1 2022 | 3 |
AMYLYX PHARMACEUTICALS... | 3 | 3 | 0.00% | 0.04% | 0.11% | Q1 2022 | Q3 2022 | 3 | |
ACST | ACASTI PHARMA INC | 3 | 3 | 0.03% | 0.04% | 0.06% | Q4 2018 | Q2 2019 | 3 |
RPTX | REPARE THERAPEUTICS INC | 3 | 3 | 0.02% | 0.04% | 0.05% | Q1 2021 | Q3 2021 | 3 |
ALPN | ALPINE IMMUNE SCIENCES... | 2 | 1 | 0.01% | 0.04% | 0.06% | Q4 2020 | Q4 2022 | 3 |
IMCR | IMMUNOCORE HLDGS PLC | 2 | 1 | 0.01% | 0.03% | 0.06% | Q3 2021 | Q2 2022 | 3 |
TANGO THERAPEUTICS INC | 3 | 3 | 0.02% | 0.03% | 0.03% | Q3 2021 | Q1 2022 | 3 | |
ABOS | ACUMEN PHARMACEUTICALS... | 3 | 3 | 0.02% | 0.03% | 0.03% | Q3 2021 | Q1 2022 | 3 |
KRYSTAL BIOTECH INC | 3 | 3 | 0.02% | 0.03% | 0.03% | Q2 2021 | Q4 2021 | 3 | |
AVEO | AVEO PHARMACEUTICALS INC | 3 | 3 | 0.02% | 0.02% | 0.03% | Q2 2021 | Q4 2021 | 3 |
SNSE | SENSEI BIOTHERAPEUTICS... | 3 | 3 | 0.01% | 0.01% | 0.03% | Q1 2021 | Q3 2021 | 3 |
RLMD | RELMADA THERAPEUTICS INC | 2 | 1 | 0.00% | 0.01% | 0.01% | Q4 2021 | Q4 2022 | 3 |
MTCR | METACRINE INC | 3 | 3 | 0.00% | 0.01% | 0.01% | Q4 2021 | Q2 2022 | 3 |
ACHIEVE LIFE SCIENCES INC | 2 | 1 | 0.00% | 0.00% | 0.01% | Q2 2021 | Q1 2022 | 3 | |
UNH | UNITEDHEALTH GROUP INC | 2 | 2 | 2.30% | 2.99% | 3.67% | Q4 2016 | Q1 2017 | 2 |
STJ | ST JUDE MED INC | 2 | 2 | 2.39% | 2.88% | 3.37% | Q4 2014 | Q1 2015 | 2 |
BCR | BARD C R INC | 1 | 1 | 2.38% | 2.42% | 2.45% | Q4 2014 | Q3 2016 | 2 |
CI | CIGNA CORPORATION | 1 | 1 | 1.34% | 2.40% | 3.47% | Q1 2015 | Q1 2018 | 2 |
TMO | THERMO FISHER SCIENTIF... | 2 | 2 | 2.08% | 2.28% | 2.49% | Q1 2015 | Q2 2015 | 2 |
JOHNSON & JOHNSON | 1 | 1 | 0.86% | 2.21% | 3.55% | Q1 2022 | Q3 2023 | 2 | |
BAX | BAXTER INTL INC | 1 | 1 | 1.89% | 2.18% | 2.48% | Q4 2014 | Q3 2017 | 2 |
BSX | BOSTON SCIENTIFIC CORP | 1 | 1 | 1.59% | 2.10% | 2.62% | Q4 2016 | Q2 2018 | 2 |
NUVA | NUVASIVE INC | 1 | 1 | 1.53% | 2.09% | 2.65% | Q1 2016 | Q2 2017 | 2 |
ALXN | ALEXION PHARMACEUTICAL... | 1 | 1 | 1.86% | 1.92% | 1.98% | Q2 2016 | Q1 2018 | 2 |
LLY | LILLY ELI & CO | 1 | 1 | 1.18% | 1.83% | 2.47% | Q4 2014 | Q1 2020 | 2 |
WBA | WALGREENS BOOTS ALLIAN... | 2 | 2 | 1.58% | 1.78% | 1.98% | Q3 2017 | Q4 2017 | 2 |
AZN | ASTRAZENECA PLC | 1 | 1 | 0.83% | 1.77% | 2.71% | Q2 2017 | Q3 2018 | 2 |
WAT | WATERS CORP | 1 | 1 | 1.62% | 1.76% | 1.91% | Q1 2017 | Q3 2019 | 2 |
PTCT | PTC THERAPEUTICS INC | 2 | 2 | 1.48% | 1.68% | 1.88% | Q1 2015 | Q2 2015 | 2 |
A | AGILENT TECHNOLOGIES INC | 2 | 2 | 1.29% | 1.63% | 1.97% | Q1 2015 | Q2 2015 | 2 |
PRGO | PERRIGO CO PLC | 2 | 2 | 1.57% | 1.63% | 1.68% | Q2 2015 | Q3 2015 | 2 |
REGN | REGENERON PHARMACEUTICALS | 1 | 1 | 0.85% | 1.61% | 2.37% | Q3 2018 | Q3 2019 | 2 |
PRAH | PRA HEALTH SCIENCES INC | 2 | 2 | 1.00% | 1.58% | 2.16% | Q2 2017 | Q3 2017 | 2 |
RMD | RESMED INC | 1 | 1 | 0.19% | 1.57% | 2.95% | Q4 2014 | Q3 2022 | 2 |
GH | GUARDANT HEALTH INC | 2 | 2 | 1.24% | 1.55% | 1.86% | Q1 2019 | Q2 2019 | 2 |
CPHD | CEPHEID | 1 | 1 | 1.24% | 1.47% | 1.71% | Q2 2015 | Q2 2016 | 2 |
GRFS | GRIFOLS S A | 2 | 2 | 1.18% | 1.44% | 1.70% | Q3 2019 | Q4 2019 | 2 |
AGN | ALLERGAN INC | 1 | 1 | 1.19% | 1.42% | 1.66% | Q4 2014 | Q2 2015 | 2 |
ARKG | ARK ETF TR | 2 | 2 | 1.07% | 1.42% | 1.77% | Q4 2020 | Q1 2021 | 2 |
A | AGILENT TECHNOLOGIES INC | 2 | 2 | 1.15% | 1.39% | 1.63% | Q4 2015 | Q1 2016 | 2 |
AMGN | AMGEN INC | 2 | 2 | 1.29% | 1.30% | 1.31% | Q3 2018 | Q4 2018 | 2 |
COO | COOPER COS INC | 1 | 1 | 0.50% | 1.29% | 2.09% | Q4 2014 | Q1 2021 | 2 |
CNC | CENTENE CORP DEL | 1 | 1 | 0.11% | 1.29% | 2.47% | Q2 2018 | Q4 2020 | 2 |
GWPH | GW PHARMACEUTICALS PLC | 1 | 1 | 0.70% | 1.19% | 1.68% | Q2 2016 | Q2 2018 | 2 |
ILMN | ILLUMINA INC | 1 | 1 | 0.61% | 1.12% | 1.64% | Q4 2016 | Q3 2022 | 2 |
TRNX | TORNIER N V | 2 | 2 | 0.93% | 1.08% | 1.24% | Q4 2014 | Q1 2015 | 2 |
VNDA | VANDA PHARMACEUTICALS INC | 1 | 1 | 0.18% | 1.04% | 1.91% | Q4 2017 | Q4 2018 | 2 |
ALNY | ALNYLAM PHARMACEUTICAL... | 1 | 1 | 0.81% | 1.04% | 1.27% | Q3 2016 | Q2 2022 | 2 |
ABMD | ABIOMED INC | 1 | 1 | 0.81% | 1.04% | 1.26% | Q1 2017 | Q1 2019 | 2 |
QDEL | QUIDEL CORP | 1 | 1 | 0.60% | 1.01% | 1.41% | Q3 2017 | Q1 2020 | 2 |
ALIM | ALIMERA SCIENCES INC | 1 | 1 | 0.42% | 1.00% | 1.58% | Q4 2014 | Q3 2015 | 2 |
B108PS | ACTAVIS PLC | 2 | 2 | 0.32% | 1.00% | 1.67% | Q4 2014 | Q1 2015 | 2 |
ZLTQ | ZELTIQ AESTHETICS INC | 1 | 1 | 0.91% | 0.99% | 1.07% | Q3 2015 | Q3 2016 | 2 |
INOVALON HLDGS INC | 2 | 2 | 0.34% | 0.98% | 1.63% | Q2 2021 | Q3 2021 | 2 | |
DHR | DANAHER CORPORATION | 2 | 2 | 0.84% | 0.96% | 1.08% | Q1 2019 | Q2 2019 | 2 |
MEDTRONIC PLC | 1 | 1 | 0.46% | 0.95% | 1.44% | Q3 2021 | Q1 2022 | 2 | |
ADMS | ADAMAS PHARMACEUTICALS... | 2 | 2 | 0.55% | 0.89% | 1.23% | Q1 2017 | Q2 2017 | 2 |
HUMANA INC | 1 | 1 | 0.53% | 0.89% | 1.24% | Q3 2021 | Q4 2022 | 2 | |
MOH | MOLINA HEALTHCARE INC | 1 | 1 | 0.50% | 0.87% | 1.24% | Q3 2016 | Q3 2017 | 2 |
SIEN | SIENTRA INC | 2 | 2 | 0.34% | 0.87% | 1.40% | Q4 2018 | Q1 2019 | 2 |
AMN HEALTHCARE SVCS INC | 2 | 2 | 0.66% | 0.86% | 1.05% | Q3 2021 | Q4 2021 | 2 | |
MDVN | MEDIVATION INC | 2 | 2 | 0.78% | 0.85% | 0.93% | Q1 2016 | Q2 2016 | 2 |
ELAN | ELANCO ANIMAL HEALTH INC | 1 | 1 | 0.73% | 0.84% | 0.95% | Q3 2018 | Q3 2023 | 2 |
MDGL | MADRIGAL PHARMACEUTICA... | 2 | 2 | 0.17% | 0.82% | 1.47% | Q2 2018 | Q3 2018 | 2 |
TNDM | TANDEM DIABETES CARE INC | 1 | 1 | 0.41% | 0.82% | 1.22% | Q1 2015 | Q4 2015 | 2 |
CGC | CANOPY GROWTH CORP | 2 | 2 | 0.56% | 0.82% | 1.08% | Q3 2019 | Q4 2019 | 2 |
ANGO | ANGIODYNAMICS INC | 1 | 1 | 0.45% | 0.80% | 1.15% | Q1 2015 | Q2 2018 | 2 |
HZNP | HORIZON PHARMA PLC | 1 | 1 | 0.71% | 0.77% | 0.83% | Q3 2016 | Q2 2017 | 2 |
ARENA PHARMACEUTICALS INC | 2 | 2 | 0.54% | 0.76% | 0.98% | Q3 2021 | Q4 2021 | 2 | |
DVA | DAVITA INC | 1 | 1 | 0.74% | 0.76% | 0.77% | Q1 2019 | Q4 2019 | 2 |
INGN | INOGEN INC | 1 | 1 | 0.51% | 0.75% | 0.99% | Q4 2018 | Q2 2019 | 2 |
SWAV | SHOCKWAVE MED INC | 1 | 1 | 0.44% | 0.74% | 1.04% | Q1 2019 | Q3 2023 | 2 |
MYL | MYLAN NV | 2 | 2 | 0.38% | 0.74% | 1.09% | Q2 2018 | Q3 2018 | 2 |
ELEVANCE HEALTH INC | 2 | 2 | 0.53% | 0.72% | 0.92% | Q3 2022 | Q4 2022 | 2 | |
SUPN | SUPERNUS PHARMACEUTICA... | 1 | 1 | 0.47% | 0.72% | 0.97% | Q1 2017 | Q3 2019 | 2 |
SHOCKWAVE MED INC | 1 | 1 | 0.30% | 0.71% | 1.13% | Q3 2021 | Q2 2023 | 2 | |
LHCG | LHC GROUP INC | 2 | 2 | 0.25% | 0.68% | 1.11% | Q2 2020 | Q3 2020 | 2 |
VERTEX PHARMACEUTICALS... | 2 | 2 | 0.55% | 0.66% | 0.77% | Q3 2021 | Q4 2021 | 2 | |
AFIB | ACUTUS MED INC | 2 | 2 | 0.49% | 0.66% | 0.82% | Q3 2020 | Q4 2020 | 2 |
EHC | ENCOMPASS HEALTH CORP | 1 | 1 | 0.47% | 0.64% | 0.82% | Q3 2018 | Q1 2019 | 2 |
HEALTHEQUITY INC | 2 | 2 | 0.39% | 0.64% | 0.89% | Q1 2022 | Q2 2022 | 2 | |
CYTK | CYTOKINETICS INC | 2 | 2 | 0.58% | 0.63% | 0.68% | Q3 2022 | Q4 2022 | 2 |
ACAD | ACADIA PHARMACEUTICALS... | 1 | 1 | 0.04% | 0.62% | 1.19% | Q3 2016 | Q4 2021 | 2 |
CDTX | CIDARA THERAPEUTICS INC | 1 | 1 | 0.45% | 0.61% | 0.78% | Q2 2017 | Q4 2017 | 2 |
MOLSON COORS BEVERAGE CO | 2 | 2 | 0.38% | 0.60% | 0.82% | Q1 2022 | Q2 2022 | 2 | |
QGEN | QIAGEN NV | 1 | 1 | 0.14% | 0.56% | 0.97% | Q4 2019 | Q4 2020 | 2 |
FEIC | FEI CO | 2 | 2 | 0.42% | 0.54% | 0.66% | Q2 2015 | Q3 2015 | 2 |
MDT | MEDTRONIC PLC | 1 | 1 | 0.50% | 0.53% | 0.56% | Q2 2020 | Q1 2021 | 2 |
OPHT | OPHTHOTECH CORP | 2 | 2 | 0.52% | 0.53% | 0.54% | Q2 2016 | Q3 2016 | 2 |
NVRO | NEVRO CORP | 1 | 1 | 0.09% | 0.52% | 0.95% | Q4 2019 | Q4 2020 | 2 |
EHTH | EHEALTH INC | 1 | 1 | 0.27% | 0.52% | 0.78% | Q4 2014 | Q1 2019 | 2 |
PKI | PERKINELMER INC | 1 | 1 | 0.24% | 0.52% | 0.80% | Q4 2019 | Q1 2021 | 2 |
QUEST DIAGNOSTICS INC | 1 | 1 | 0.20% | 0.51% | 0.82% | Q2 2021 | Q1 2022 | 2 | |
THC | TENET HEALTHCARE CORP | 1 | 1 | 0.30% | 0.51% | 0.72% | Q3 2016 | Q3 2022 | 2 |
ANIP | ANI PHARMACEUTICALS INC | 2 | 2 | 0.42% | 0.50% | 0.58% | Q4 2016 | Q1 2017 | 2 |
XLRN | ACCELERON PHARMA INC | 2 | 2 | 0.19% | 0.50% | 0.82% | Q1 2020 | Q2 2020 | 2 |
ACER | ACER THERAPEUTICS INC | 2 | 2 | 0.48% | 0.50% | 0.53% | Q4 2017 | Q1 2018 | 2 |
MASI | MASIMO CORP | 2 | 2 | 0.33% | 0.50% | 0.67% | Q2 2020 | Q3 2020 | 2 |
PBYI | PUMA BIOTECHNOLOGY INC | 1 | 1 | 0.10% | 0.49% | 0.88% | Q3 2017 | Q1 2019 | 2 |
AXDX | ACCELERATE DIAGNOSTICS... | 2 | 2 | 0.34% | 0.48% | 0.63% | Q2 2018 | Q3 2018 | 2 |
TENET HEALTHCARE CORP | 2 | 2 | 0.26% | 0.47% | 0.67% | Q4 2021 | Q1 2022 | 2 | |
AIMT | AIMMUNE THERAPEUTICS INC | 1 | 1 | 0.45% | 0.47% | 0.48% | Q1 2017 | Q1 2018 | 2 |
LANTHEUS HLDGS INC | 2 | 2 | 0.44% | 0.46% | 0.49% | Q2 2023 | Q3 2023 | 2 | |
GILD | GILEAD SCIENCES INC | 1 | 1 | 0.42% | 0.46% | 0.49% | Q1 2020 | Q4 2020 | 2 |
HENRY SCHEIN INC | 1 | 1 | 0.31% | 0.44% | 0.58% | Q2 2022 | Q4 2022 | 2 | |
CSII | CARDIOVASCULAR SYS INC... | 1 | 1 | 0.12% | 0.44% | 0.75% | Q2 2018 | Q3 2020 | 2 |
OLAPLEX HLDGS INC | 2 | 2 | 0.42% | 0.43% | 0.45% | Q3 2021 | Q4 2021 | 2 | |
NUVASIVE INC | 2 | 2 | 0.41% | 0.43% | 0.46% | Q3 2021 | Q4 2021 | 2 | |
IRHYTHM TECHNOLOGIES INC | 1 | 1 | 0.34% | 0.43% | 0.52% | Q3 2022 | Q2 2023 | 2 | |
INSM | INSMED INC | 1 | 1 | 0.02% | 0.41% | 0.80% | Q3 2017 | Q4 2021 | 2 |
CMIIU | CM LIFE SCIENCES II INC | 2 | 2 | 0.38% | 0.41% | 0.44% | Q1 2021 | Q2 2021 | 2 |
AXNX | AXONICS MODULATION TEC... | 1 | 1 | 0.40% | 0.40% | 0.40% | Q2 2019 | Q4 2019 | 2 |
BYND | BEYOND MEAT INC | 2 | 2 | 0.36% | 0.40% | 0.44% | Q3 2019 | Q4 2019 | 2 |
CSTL | CASTLE BIOSCIENCES INC | 1 | 1 | 0.39% | 0.40% | 0.41% | Q3 2019 | Q1 2020 | 2 |
CNCE | CONCERT PHARMACEUTICAL... | 2 | 2 | 0.39% | 0.40% | 0.41% | Q1 2019 | Q2 2019 | 2 |
EXAS | EXACT SCIENCES CORP | 1 | 1 | 0.21% | 0.39% | 0.56% | Q3 2016 | Q3 2020 | 2 |
MAPS | WM TECHNOLOGY INC | 1 | 1 | 0.04% | 0.38% | 0.71% | Q3 2021 | Q1 2022 | 2 |
ABCL | ABCELLERA BIOLOGICS INC | 2 | 2 | 0.22% | 0.38% | 0.53% | Q4 2020 | Q1 2021 | 2 |
NVCR | NOVOCURE LTD | 2 | 2 | 0.32% | 0.38% | 0.44% | Q1 2020 | Q2 2020 | 2 |
OBSV | OBSEVA SA | 2 | 2 | 0.19% | 0.37% | 0.55% | Q2 2018 | Q3 2018 | 2 |
JWS | JAWS ACQUISITION CORP | 2 | 2 | 0.34% | 0.37% | 0.40% | Q4 2020 | Q1 2021 | 2 |
CERS | CERUS CORP | 2 | 2 | 0.36% | 0.37% | 0.37% | Q1 2020 | Q2 2020 | 2 |
RCM | R1 RCM INC | 2 | 2 | 0.19% | 0.36% | 0.53% | Q3 2019 | Q4 2019 | 2 |
OSUR | ORASURE TECHNOLOGIES INC | 2 | 2 | 0.17% | 0.36% | 0.54% | Q1 2020 | Q2 2020 | 2 |
IMVTU | IMMUNOVANT INC | 2 | 2 | 0.34% | 0.35% | 0.36% | Q4 2019 | Q1 2020 | 2 |
NVTA | INVITAE CORP | 2 | 2 | 0.27% | 0.34% | 0.41% | Q2 2020 | Q3 2020 | 2 |
IMMU | IMMUNOMEDICS INC | 2 | 2 | 0.26% | 0.34% | 0.41% | Q4 2019 | Q1 2020 | 2 |
ELANCO ANIMAL HEALTH INC | 2 | 2 | 0.26% | 0.33% | 0.40% | Q2 2023 | Q3 2023 | 2 | |
OPCH | OPTION CARE HEALTH INC | 2 | 2 | 0.22% | 0.33% | 0.44% | Q3 2020 | Q4 2020 | 2 |
ESRX | EXPRESS SCRIPTS HLDG CO | 2 | 2 | 0.28% | 0.33% | 0.38% | Q2 2017 | Q3 2017 | 2 |
ABIOMED INC | 1 | 1 | 0.30% | 0.33% | 0.36% | Q3 2021 | Q2 2022 | 2 | |
AMYRIS INC | 1 | 1 | 0.19% | 0.31% | 0.43% | Q4 2021 | Q2 2022 | 2 | |
NATERA INC | 1 | 1 | 0.25% | 0.31% | 0.36% | Q1 2022 | Q3 2022 | 2 | |
CLLS | CELLECTIS S A | 2 | 2 | 0.21% | 0.30% | 0.40% | Q2 2018 | Q3 2018 | 2 |
TTOO | T2 BIOSYSTEMS INC | 1 | 1 | 0.13% | 0.30% | 0.46% | Q3 2016 | Q2 2018 | 2 |
GBT | GLOBAL BLOOD THERAPEUT... | 1 | 1 | 0.19% | 0.30% | 0.41% | Q2 2018 | Q4 2018 | 2 |
KALA | KALA PHARMACEUTICALS INC | 1 | 1 | 0.14% | 0.30% | 0.46% | Q1 2018 | Q1 2020 | 2 |
SHC | SOTERA HEALTH CO | 1 | 1 | 0.12% | 0.29% | 0.47% | Q4 2020 | Q2 2023 | 2 |
CLDN | CELLADON CORP | 2 | 2 | 0.24% | 0.28% | 0.33% | Q4 2014 | Q1 2015 | 2 |
AMN | AMN HEALTHCARE SVCS INC | 1 | 1 | 0.28% | 0.28% | 0.29% | Q3 2021 | Q2 2023 | 2 |
TERN | TERNS PHARMACEUTICALS INC | 2 | 2 | 0.25% | 0.28% | 0.32% | Q3 2022 | Q4 2022 | 2 |
FULGENT GENETICS INC | 2 | 2 | 0.27% | 0.28% | 0.29% | Q2 2021 | Q3 2021 | 2 | |
NVST | ENVISTA HOLDINGS CORPO... | 2 | 2 | 0.23% | 0.28% | 0.33% | Q4 2020 | Q1 2021 | 2 |
MOTS | MOTUS GI HLDGS INC | 2 | 2 | 0.26% | 0.28% | 0.29% | Q1 2018 | Q2 2018 | 2 |
RGNX | REGENXBIO INC | 2 | 2 | 0.23% | 0.28% | 0.33% | Q2 2017 | Q3 2017 | 2 |
GH | GUARDANT HEALTH INC | 1 | 1 | 0.09% | 0.27% | 0.45% | Q4 2019 | Q4 2020 | 2 |
DYAX | DYAX CORP | 2 | 2 | 0.26% | 0.27% | 0.28% | Q2 2015 | Q3 2015 | 2 |
OCDX | ORTHO CLINICAL DIAGNOS... | 1 | 1 | 0.23% | 0.27% | 0.31% | Q1 2021 | Q3 2021 | 2 |
KRMD | REPRO MED SYS INC | 2 | 2 | 0.15% | 0.26% | 0.37% | Q2 2020 | Q3 2020 | 2 |
PFIZER INC | 2 | 2 | 0.25% | 0.26% | 0.26% | Q3 2022 | Q4 2022 | 2 | |
ARENA PHARMACEUTICALS INC | 2 | 2 | 0.18% | 0.25% | 0.33% | Q3 2021 | Q4 2021 | 2 | |
RVNC | REVANCE THERAPEUTICS INC | 1 | 1 | 0.10% | 0.25% | 0.40% | Q3 2017 | Q2 2020 | 2 |
CLSD | CLEARSIDE BIOMEDICAL INC | 1 | 1 | 0.06% | 0.25% | 0.43% | Q1 2018 | Q3 2018 | 2 |
SCHRODINGER INC | 2 | 2 | 0.20% | 0.24% | 0.28% | Q1 2022 | Q2 2022 | 2 | |
FLDM | FLUIDIGM CORP DEL | 1 | 1 | 0.24% | 0.24% | 0.24% | Q3 2018 | Q3 2019 | 2 |
PTLA | PORTOLA PHARMACEUTICAL... | 2 | 2 | 0.20% | 0.24% | 0.28% | Q4 2018 | Q1 2019 | 2 |
BAUSCH HEALTH COS INC | 2 | 2 | 0.10% | 0.23% | 0.36% | Q3 2021 | Q4 2021 | 2 | |
INSPIRE MED SYS INC | 2 | 2 | 0.16% | 0.23% | 0.29% | Q4 2021 | Q1 2022 | 2 | |
BLFS | BIOLIFE SOLUTIONS INC | 2 | 2 | 0.22% | 0.22% | 0.23% | Q3 2020 | Q4 2020 | 2 |
MRSN | MERSANA THERAPEUTICS INC | 1 | 1 | 0.15% | 0.22% | 0.29% | Q1 2019 | Q2 2020 | 2 |
FLXN | FLEXION THERAPEUTICS INC | 1 | 1 | 0.16% | 0.22% | 0.28% | Q1 2017 | Q2 2020 | 2 |
AMERISOURCEBERGEN CORP | 2 | 2 | 0.14% | 0.21% | 0.29% | Q2 2022 | Q3 2022 | 2 | |
OAK STR HEALTH INC | 1 | 1 | 0.14% | 0.21% | 0.28% | Q4 2021 | Q3 2022 | 2 | |
CUREVAC N V | 2 | 2 | 0.13% | 0.21% | 0.29% | Q2 2021 | Q3 2021 | 2 | |
CYTK | CYTOKINETICS INC | 1 | 1 | 0.04% | 0.20% | 0.37% | Q3 2019 | Q3 2022 | 2 |
AGEN | AGENUS INC | 1 | 1 | 0.09% | 0.20% | 0.31% | Q2 2017 | Q4 2017 | 2 |
2SEVENTY BIO INC | 2 | 2 | 0.12% | 0.20% | 0.27% | Q3 2022 | Q4 2022 | 2 | |
GTH | GENETRON HLDGS LTD | 1 | 1 | 0.14% | 0.19% | 0.25% | Q2 2020 | Q4 2020 | 2 |
SELB | SELECTA BIOSCIENCES INC | 1 | 1 | 0.18% | 0.18% | 0.19% | Q3 2018 | Q1 2020 | 2 |
THE BEAUTY HEALTH COMPANY | 2 | 2 | 0.08% | 0.18% | 0.29% | Q1 2022 | Q2 2022 | 2 | |
BLUE | BLUEBIRD BIO INC | 1 | 1 | 0.03% | 0.17% | 0.32% | Q2 2018 | Q3 2022 | 2 |
KRA | KRATON CORPORATION | 2 | 2 | 0.13% | 0.17% | 0.21% | Q4 2020 | Q1 2021 | 2 |
CUREVAC N V | 1 | 1 | 0.03% | 0.17% | 0.30% | Q2 2021 | Q4 2022 | 2 | |
DFHT | DEERFIELD HEALTHCARE T... | 2 | 2 | 0.13% | 0.17% | 0.21% | Q4 2020 | Q1 2021 | 2 |
PROCEPT BIOROBOTICS CORP | 2 | 2 | 0.14% | 0.16% | 0.19% | Q3 2021 | Q4 2021 | 2 | |
TLOG | TETRALOGIC PHARMACEUTI... | 2 | 2 | 0.14% | 0.16% | 0.18% | Q4 2014 | Q1 2015 | 2 |
ACADIA PHARMACEUTICALS... | 2 | 2 | 0.16% | 0.16% | 0.16% | Q1 2022 | Q2 2022 | 2 | |
HOLX | HOLOGIC INC | 2 | 2 | 0.11% | 0.16% | 0.21% | Q4 2020 | Q1 2021 | 2 |
KDMN | KADMON HLDGS INC | 1 | 1 | 0.01% | 0.16% | 0.30% | Q4 2017 | Q3 2021 | 2 |
BNTX | BIONTECH SE | 1 | 1 | 0.09% | 0.16% | 0.22% | Q4 2021 | Q4 2022 | 2 |
QTNT | QUOTIENT LTD | 2 | 2 | 0.14% | 0.15% | 0.16% | Q1 2019 | Q2 2019 | 2 |
SAREPTA THERAPEUTICS INC | 2 | 2 | 0.15% | 0.15% | 0.15% | Q3 2022 | Q4 2022 | 2 | |
EIGR | EIGER BIOPHARMACEUTICA... | 2 | 2 | 0.10% | 0.15% | 0.20% | Q2 2018 | Q3 2018 | 2 |
RAPID MICRO BIOSYSTEMS... | 2 | 2 | 0.11% | 0.15% | 0.19% | Q3 2021 | Q4 2021 | 2 | |
INARI MED INC | 2 | 2 | 0.10% | 0.14% | 0.18% | Q3 2022 | Q4 2022 | 2 | |
LSAQ | LIFESCI ACQUISITION II... | 2 | 2 | 0.13% | 0.14% | 0.16% | Q4 2020 | Q1 2021 | 2 |
NLTX | NEOLEUKIN THERAPEUTICS... | 2 | 2 | 0.13% | 0.14% | 0.14% | Q4 2019 | Q1 2020 | 2 |
SNDX | SYNDAX PHARMACEUTICALS... | 2 | 2 | 0.10% | 0.13% | 0.17% | Q3 2018 | Q4 2018 | 2 |
VERU INC | 2 | 2 | 0.13% | 0.13% | 0.13% | Q2 2022 | Q3 2022 | 2 | |
CRIS | CURIS INC | 2 | 2 | 0.06% | 0.12% | 0.19% | Q4 2020 | Q1 2021 | 2 |
CRBP | CORBUS PHARMACEUTICALS... | 2 | 2 | 0.11% | 0.12% | 0.14% | Q1 2020 | Q2 2020 | 2 |
THE BEAUTY HEALTH COMPANY | 1 | 1 | 0.09% | 0.12% | 0.15% | Q4 2022 | Q2 2023 | 2 | |
IMMUNOGEN INC | 2 | 2 | 0.11% | 0.12% | 0.13% | Q3 2021 | Q4 2021 | 2 | |
NSPR | INSPIREMD INC | 2 | 2 | 0.02% | 0.12% | 0.22% | Q2 2023 | Q3 2023 | 2 |
ORGANOGENESIS HLDGS INC | 2 | 2 | 0.12% | 0.12% | 0.12% | Q3 2021 | Q4 2021 | 2 | |
TMDX | TRANSMEDICS GROUP INC | 1 | 1 | 0.05% | 0.12% | 0.18% | Q3 2020 | Q1 2021 | 2 |
AMICUS THERAPEUTICS INC | 2 | 2 | 0.06% | 0.11% | 0.17% | Q2 2021 | Q3 2021 | 2 | |
ZNTL | ZENTALIS PHARMACEUTICA... | 2 | 2 | 0.07% | 0.11% | 0.15% | Q1 2021 | Q2 2021 | 2 |
RXDX | PROMETHEUS BIOSCIENCES... | 2 | 2 | 0.10% | 0.11% | 0.12% | Q3 2022 | Q4 2022 | 2 |
ACETQ | ACETO CORP | 2 | 2 | 0.10% | 0.11% | 0.12% | Q3 2018 | Q4 2018 | 2 |
ANNX | ANNEXON INC | 2 | 2 | 0.08% | 0.11% | 0.13% | Q3 2022 | Q4 2022 | 2 |
TWIST BIOSCIENCE CORP | 1 | 1 | 0.08% | 0.10% | 0.12% | Q2 2021 | Q4 2022 | 2 | |
APYX MEDICAL CORPORATION | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2022 | Q4 2022 | 2 | |
MGNX | MACROGENICS INC | 1 | 1 | 0.04% | 0.10% | 0.16% | Q1 2019 | Q1 2021 | 2 |
FATE THERAPEUTICS INC | 2 | 2 | 0.09% | 0.10% | 0.10% | Q3 2021 | Q4 2021 | 2 | |
XGN | EXAGEN INC | 2 | 2 | 0.02% | 0.09% | 0.16% | Q1 2021 | Q2 2021 | 2 |
ORAMED PHARMACEUTICALS... | 2 | 2 | 0.07% | 0.09% | 0.12% | Q3 2022 | Q4 2022 | 2 | |
IMMUNIC INC | 2 | 2 | 0.07% | 0.09% | 0.11% | Q1 2022 | Q2 2022 | 2 | |
CRIS | CURIS INC | 2 | 2 | 0.01% | 0.09% | 0.16% | Q3 2020 | Q4 2020 | 2 |
VRCA | VERRICA PHARMACEUTICAL... | 2 | 2 | 0.07% | 0.09% | 0.10% | Q3 2018 | Q4 2018 | 2 |
OMIC | SINGULAR GENOMICS SYST... | 1 | 1 | 0.04% | 0.09% | 0.13% | Q2 2021 | Q4 2021 | 2 |
VAPO | VAPOTHERM INC | 1 | 1 | 0.02% | 0.08% | 0.15% | Q3 2020 | Q1 2021 | 2 |
NKTR | NEKTAR THERAPEUTICS | 1 | 1 | 0.05% | 0.08% | 0.12% | Q4 2020 | Q3 2021 | 2 |
GOSSAMER BIO INC | 2 | 2 | 0.05% | 0.08% | 0.12% | Q2 2022 | Q3 2022 | 2 | |
GERON CORP | 2 | 2 | 0.08% | 0.08% | 0.08% | Q3 2022 | Q4 2022 | 2 | |
GERN | GERON CORP | 1 | 1 | 0.07% | 0.08% | 0.09% | Q4 2014 | Q3 2022 | 2 |
INO | INOVIO PHARMACEUTICALS... | 1 | 1 | 0.05% | 0.08% | 0.10% | Q2 2020 | Q1 2021 | 2 |
DYNS | DYNAMICS SPECIAL PURPO... | 2 | 2 | 0.08% | 0.08% | 0.08% | Q2 2021 | Q3 2021 | 2 |
OCUL | OCULAR THERAPEUTIX INC | 1 | 1 | 0.03% | 0.08% | 0.12% | Q1 2016 | Q3 2018 | 2 |
NNOX | NANO X IMAGING LTD | 2 | 2 | 0.03% | 0.08% | 0.12% | Q4 2020 | Q1 2021 | 2 |
CORTEXYME INC | 2 | 2 | 0.02% | 0.07% | 0.12% | Q3 2021 | Q4 2021 | 2 | |
ACET | ADICET BIO INC | 2 | 2 | 0.04% | 0.06% | 0.09% | Q4 2021 | Q1 2022 | 2 |
ARCUS BIOSCIENCES INC | 1 | 1 | 0.05% | 0.06% | 0.08% | Q2 2021 | Q1 2022 | 2 | |
CRBP | CORBUS PHARMACEUTICALS... | 1 | 1 | 0.04% | 0.06% | 0.08% | Q1 2020 | Q3 2020 | 2 |
ABEO | ABEONA THERAPEUTICS INC | 2 | 2 | 0.05% | 0.06% | 0.07% | Q4 2019 | Q1 2020 | 2 |
PROMETHEUS BIOSCIENCES... | 2 | 2 | 0.04% | 0.06% | 0.07% | Q3 2022 | Q4 2022 | 2 | |
VERO | VENUS CONCEPT INC | 2 | 2 | 0.05% | 0.06% | 0.07% | Q1 2021 | Q2 2021 | 2 |
BCAB | BIOATLA INC | 2 | 2 | 0.01% | 0.05% | 0.09% | Q4 2020 | Q1 2021 | 2 |
FNCH | FINCH THERAPEUTICS GRO... | 2 | 2 | 0.03% | 0.05% | 0.07% | Q1 2021 | Q2 2021 | 2 |
MLND | MILLENDO THERAPEUTICS INC | 2 | 2 | 0.02% | 0.05% | 0.08% | Q1 2020 | Q2 2020 | 2 |
EOLS | EVOLUS INC | 2 | 2 | 0.04% | 0.05% | 0.06% | Q2 2020 | Q3 2020 | 2 |
AVADEL PHARMACEUTICALS... | 2 | 2 | 0.04% | 0.05% | 0.06% | Q2 2021 | Q3 2021 | 2 | |
CHAQ | CHARDAN HEALTHCR ACQST... | 2 | 2 | 0.04% | 0.05% | 0.05% | Q1 2021 | Q2 2021 | 2 |
CERE | CEREVEL THERAPEUTICS H... | 2 | 2 | 0.02% | 0.04% | 0.07% | Q3 2022 | Q4 2022 | 2 |
INO | INOVIO PHARMACEUTICALS... | 1 | 1 | 0.01% | 0.04% | 0.08% | Q3 2020 | Q1 2021 | 2 |
AFMD | AFFIMED N V | 2 | 2 | 0.02% | 0.04% | 0.05% | Q4 2020 | Q1 2021 | 2 |
ACHL | ACHILLES THERAPEUTICS PLC | 2 | 2 | 0.02% | 0.04% | 0.05% | Q1 2021 | Q2 2021 | 2 |
MGNX | MACROGENICS INC | 1 | 1 | 0.01% | 0.04% | 0.06% | Q1 2021 | Q3 2022 | 2 |
KOD | KODIAK SCIENCES INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2018 | Q4 2021 | 2 |
UBX | UNITY BIOTECHNOLOGY INC | 2 | 2 | 0.01% | 0.03% | 0.06% | Q1 2022 | Q2 2022 | 2 |
BLUEPRINT MEDICINES CORP | 2 | 2 | 0.03% | 0.03% | 0.04% | Q2 2022 | Q3 2022 | 2 | |
FULC | FULCRUM THERAPEUTICS INC | 2 | 2 | 0.02% | 0.03% | 0.04% | Q4 2020 | Q1 2021 | 2 |
ARYA SCIENCES ACQUISIT... | 2 | 2 | 0.03% | 0.03% | 0.04% | Q3 2021 | Q4 2021 | 2 | |
BELLUS HEALTH INC NEW | 2 | 2 | 0.02% | 0.03% | 0.04% | Q3 2021 | Q4 2021 | 2 | |
NGM BIOPHARMACEUTICALS... | 2 | 2 | 0.02% | 0.03% | 0.05% | Q3 2022 | Q4 2022 | 2 | |
YMTX | YUMANITY THERAPEUTICS INC | 2 | 2 | 0.02% | 0.03% | 0.04% | Q1 2021 | Q2 2021 | 2 |
PYXIS ONCOLOGY INC | 2 | 2 | 0.02% | 0.03% | 0.04% | Q4 2021 | Q1 2022 | 2 | |
HCAQ | HEALTHCOR CATALIO ACQU... | 2 | 2 | 0.03% | 0.03% | 0.03% | Q1 2021 | Q2 2021 | 2 |
APLT | APPLIED THERAPEUTICS INC | 1 | 1 | 0.00% | 0.03% | 0.05% | Q4 2019 | Q4 2022 | 2 |
CARIBOU BIOSCIENCES INC | 2 | 2 | 0.02% | 0.03% | 0.03% | Q3 2021 | Q4 2021 | 2 | |
UNITY BIOTECHNOLOGY INC | 2 | 2 | 0.03% | 0.03% | 0.03% | Q1 2022 | Q2 2022 | 2 | |
LEXICON PHARMACEUTICAL... | 1 | 1 | 0.01% | 0.03% | 0.04% | Q2 2021 | Q2 2022 | 2 | |
NKTX | NKARTA INC | 2 | 2 | 0.01% | 0.03% | 0.04% | Q4 2020 | Q1 2021 | 2 |
TBPH | THERAVANCE BIOPHARMA INC | 2 | 2 | 0.02% | 0.02% | 0.02% | Q2 2021 | Q3 2021 | 2 |
DECIPHERA PHARMACEUTIC... | 2 | 2 | 0.01% | 0.02% | 0.02% | Q3 2021 | Q4 2021 | 2 | |
TSHA | TAYSHA GENE THERAPIES INC | 1 | 1 | 0.01% | 0.02% | 0.02% | Q3 2020 | Q2 2021 | 2 |
MREO | MEREO BIOPHARMA GROUP PLC | 2 | 2 | 0.01% | 0.01% | 0.02% | Q1 2021 | Q2 2021 | 2 |
IPHA | INNATE PHARMA S A | 2 | 2 | 0.01% | 0.01% | 0.02% | Q3 2021 | Q4 2021 | 2 |
IMRA | IMARA INC | 2 | 2 | 0.01% | 0.01% | 0.02% | Q4 2021 | Q1 2022 | 2 |
WVE | WAVE LIFE SCIENCES LTD | 2 | 2 | 0.00% | 0.01% | 0.02% | Q4 2021 | Q1 2022 | 2 |
CATABASIS PHARMACEUTIC... | 2 | 2 | 0.01% | 0.01% | 0.01% | Q1 2020 | Q2 2020 | 2 | |
ACIU | AC IMMUNE SA | 2 | 2 | 0.01% | 0.01% | 0.01% | Q3 2021 | Q4 2021 | 2 |
GLYC | GLYCOMIMETICS INC | 1 | 1 | 0.00% | 0.00% | 0.01% | Q1 2022 | Q4 2022 | 2 |
CHAQWS | CHARDAN HEALTHCR ACQST... | 2 | 2 | 0.00% | 0.00% | 0.00% | Q1 2021 | Q2 2021 | 2 |
EFFECTOR THERAPEUTICS INC | 2 | 2 | 0.00% | 0.00% | 0.00% | Q4 2021 | Q1 2022 | 2 | |
SCILEX HOLDING CO | 2 | 2 | 0.00% | 0.00% | 0.00% | Q1 2023 | Q2 2023 | 2 | |
ROCKET PHARMACEUTICALS... | 2 | 2 | 0.00% | 0.00% | 0.00% | Q2 2023 | Q3 2023 | 2 | |
SPDR S&P 500 ETF TR | 1 | 1 | 6.96% | 6.96% | 6.96% | Q1 2023 | Q1 2023 | 1 | |
ISHARES TR | 1 | 1 | 6.32% | 6.32% | 6.32% | Q1 2023 | Q1 2023 | 1 | |
INVESCO QQQ TR | 1 | 1 | 6.01% | 6.01% | 6.01% | Q1 2023 | Q1 2023 | 1 | |
ISHARES TR | 1 | 1 | 5.94% | 5.94% | 5.94% | Q1 2023 | Q1 2023 | 1 | |
OSIS | OSI SYSTEMS INC | 1 | 1 | 5.43% | 5.43% | 5.43% | Q4 2017 | Q4 2017 | 1 |
PFE | PFIZER INC | 1 | 1 | 5.22% | 5.22% | 5.22% | Q3 2017 | Q3 2017 | 1 |
FIRST TR EXCHANGE TRAD... | 1 | 1 | 4.63% | 4.63% | 4.63% | Q1 2023 | Q1 2023 | 1 | |
ATHN | ATHENAHEALTH INC | 1 | 1 | 4.62% | 4.62% | 4.62% | Q2 2018 | Q2 2018 | 1 |
LH | LABORATORY CORP AMER H... | 1 | 1 | 3.98% | 3.98% | 3.98% | Q2 2017 | Q2 2017 | 1 |
AZN | ASTRAZENECA PLC | 1 | 1 | 3.64% | 3.64% | 3.64% | Q4 2015 | Q4 2015 | 1 |
MRK | MERCK & CO INC | 1 | 1 | 3.31% | 3.31% | 3.31% | Q2 2017 | Q2 2017 | 1 |
SIRO | SIRONA DENTAL SYSTEMS INC | 1 | 1 | 2.79% | 2.79% | 2.79% | Q1 2015 | Q1 2015 | 1 |
VANECK ETF TRUST | 1 | 1 | 2.75% | 2.75% | 2.75% | Q1 2023 | Q1 2023 | 1 | |
JNJ | JOHNSON & JOHNSON | 1 | 1 | 2.66% | 2.66% | 2.66% | Q3 2015 | Q3 2015 | 1 |
IEV | ISHARES TR | 1 | 1 | 2.65% | 2.65% | 2.65% | Q4 2016 | Q4 2016 | 1 |
SELECT SECTOR SPDR TR | 1 | 1 | 2.62% | 2.62% | 2.62% | Q1 2023 | Q1 2023 | 1 | |
ESRX | EXPRESS SCRIPTS HLDG CO | 1 | 1 | 2.49% | 2.49% | 2.49% | Q4 2014 | Q4 2014 | 1 |
BMRN | BIOMARIN PHARMACEUTICA... | 1 | 1 | 2.48% | 2.48% | 2.48% | Q4 2015 | Q4 2015 | 1 |
BCR | BARD C R INC | 1 | 1 | 2.45% | 2.45% | 2.45% | Q4 2014 | Q4 2014 | 1 |
BSX | BOSTON SCIENTIFIC CORP | 1 | 1 | 2.39% | 2.39% | 2.39% | Q4 2017 | Q4 2017 | 1 |
VIEWRAY INC | 1 | 1 | 2.35% | 2.35% | 2.35% | Q1 2023 | Q1 2023 | 1 | |
DANAHER CORPORATION | 1 | 1 | 2.35% | 2.35% | 2.35% | Q3 2023 | Q3 2023 | 1 | |
MTD | METTLER TOLEDO INTERNA... | 1 | 1 | 2.32% | 2.32% | 2.32% | Q2 2018 | Q2 2018 | 1 |
SPDR SER TR | 1 | 1 | 2.31% | 2.31% | 2.31% | Q1 2023 | Q1 2023 | 1 | |
NVS | NOVARTIS A G | 1 | 1 | 2.21% | 2.21% | 2.21% | Q3 2016 | Q3 2016 | 1 |
ARKK | ARK ETF TR | 1 | 1 | 2.13% | 2.13% | 2.13% | Q1 2021 | Q1 2021 | 1 |
PKI | PERKINELMER INC | 1 | 1 | 2.05% | 2.05% | 2.05% | Q1 2017 | Q1 2017 | 1 |
ABBOTT LABS | 1 | 1 | 2.05% | 2.05% | 2.05% | Q1 2023 | Q1 2023 | 1 | |
ABCO | ADVISORY BRD CO | 1 | 1 | 2.04% | 2.04% | 2.04% | Q2 2017 | Q2 2017 | 1 |
ARK ETF TR | 1 | 1 | 2.04% | 2.04% | 2.04% | Q1 2023 | Q1 2023 | 1 | |
EVHC | ENVISION HEALTHCARE HL... | 1 | 1 | 2.03% | 2.03% | 2.03% | Q3 2016 | Q3 2016 | 1 |
MZOR | MAZOR ROBOTICS LTD | 1 | 1 | 1.99% | 1.99% | 1.99% | Q4 2017 | Q4 2017 | 1 |
NVO | NOVO-NORDISK A S | 1 | 1 | 1.98% | 1.98% | 1.98% | Q3 2018 | Q3 2018 | 1 |
ZTS | ZOETIS INC | 1 | 1 | 1.98% | 1.98% | 1.98% | Q4 2014 | Q4 2014 | 1 |
BDX | BECTON DICKINSON & CO | 1 | 1 | 1.91% | 1.91% | 1.91% | Q2 2019 | Q2 2019 | 1 |
SPY | SPDR S&P 500 ETF TR | 1 | 1 | 1.87% | 1.87% | 1.87% | Q1 2016 | Q1 2016 | 1 |
IBB | ISHARES TR | 1 | 1 | 1.86% | 1.86% | 1.86% | Q3 2019 | Q3 2019 | 1 |
ISHARES TR | 1 | 1 | 1.83% | 1.83% | 1.83% | Q3 2023 | Q3 2023 | 1 | |
ARQL | ARQULE INC | 1 | 1 | 1.78% | 1.78% | 1.78% | Q2 2019 | Q2 2019 | 1 |
ILLUMINA INC | 1 | 1 | 1.76% | 1.76% | 1.76% | Q1 2023 | Q1 2023 | 1 | |
XRAY | DENTSPLY SIRONA INC | 1 | 1 | 1.76% | 1.76% | 1.76% | Q1 2019 | Q1 2019 | 1 |
ARK ETF TR | 1 | 1 | 1.75% | 1.75% | 1.75% | Q1 2023 | Q1 2023 | 1 | |
PODD | INSULET CORP | 1 | 1 | 1.72% | 1.72% | 1.72% | Q1 2015 | Q1 2015 | 1 |
KENVUE INC | 1 | 1 | 1.71% | 1.71% | 1.71% | Q3 2023 | Q3 2023 | 1 | |
VAR | VARIAN MED SYS INC | 1 | 1 | 1.68% | 1.68% | 1.68% | Q3 2015 | Q3 2015 | 1 |
AXGT | AXOVANT SCIENCES LTD | 1 | 1 | 1.68% | 1.68% | 1.68% | Q1 2017 | Q1 2017 | 1 |
ICU MED INC | 1 | 1 | 1.67% | 1.67% | 1.67% | Q1 2023 | Q1 2023 | 1 | |
HCA | HCA HEALTHCARE INC | 1 | 1 | 1.65% | 1.65% | 1.65% | Q4 2017 | Q4 2017 | 1 |
CVS | CVS HEALTH CORP | 1 | 1 | 1.63% | 1.63% | 1.63% | Q2 2016 | Q2 2016 | 1 |
INGN | INOGEN INC | 1 | 1 | 1.60% | 1.60% | 1.60% | Q4 2016 | Q4 2016 | 1 |
KENVUE INC | 1 | 1 | 1.52% | 1.52% | 1.52% | Q3 2023 | Q3 2023 | 1 | |
SELECT SECTOR SPDR TR | 1 | 1 | 1.51% | 1.51% | 1.51% | Q1 2023 | Q1 2023 | 1 | |
XLI | SELECT SECTOR SPDR TR | 1 | 1 | 1.45% | 1.45% | 1.45% | Q4 2015 | Q4 2015 | 1 |
BXLT | BAXALTA INC | 1 | 1 | 1.44% | 1.44% | 1.44% | Q3 2015 | Q3 2015 | 1 |
MYGN | MYRIAD GENETICS INC | 1 | 1 | 1.42% | 1.42% | 1.42% | Q1 2019 | Q1 2019 | 1 |
THC | TENET HEALTHCARE CORP | 1 | 1 | 1.38% | 1.38% | 1.38% | Q3 2016 | Q3 2016 | 1 |
CVS | CVS HEALTH CORP | 1 | 1 | 1.36% | 1.36% | 1.36% | Q4 2017 | Q4 2017 | 1 |
MTD | METTLER TOLEDO INTERNA... | 1 | 1 | 1.36% | 1.36% | 1.36% | Q3 2023 | Q3 2023 | 1 |
HTWR | HEARTWARE INTL INC | 1 | 1 | 1.35% | 1.35% | 1.35% | Q4 2014 | Q4 2014 | 1 |
GMED | GLOBUS MED INC | 1 | 1 | 1.35% | 1.35% | 1.35% | Q4 2017 | Q4 2017 | 1 |
IHF | ISHARES TR | 1 | 1 | 1.32% | 1.32% | 1.32% | Q4 2020 | Q4 2020 | 1 |
FEIC | FEI CO | 1 | 1 | 1.32% | 1.32% | 1.32% | Q2 2015 | Q2 2015 | 1 |
CAH | CARDINAL HEALTH INC | 1 | 1 | 1.32% | 1.32% | 1.32% | Q4 2015 | Q4 2015 | 1 |
ZIMMER BIOMET HOLDINGS... | 1 | 1 | 1.31% | 1.31% | 1.31% | Q1 2023 | Q1 2023 | 1 | |
INMODE LTD | 1 | 1 | 1.29% | 1.29% | 1.29% | Q1 2023 | Q1 2023 | 1 | |
GE HEALTHCARE TECHNOLO... | 1 | 1 | 1.29% | 1.29% | 1.29% | Q3 2023 | Q3 2023 | 1 | |
QSII | QUALITY SYS INC | 1 | 1 | 1.28% | 1.28% | 1.28% | Q4 2016 | Q4 2016 | 1 |
GMED | GLOBUS MED INC | 1 | 1 | 1.28% | 1.28% | 1.28% | Q2 2019 | Q2 2019 | 1 |
BMY | BRISTOL-MYERS SQUIBB CO | 1 | 1 | 1.28% | 1.28% | 1.28% | Q4 2017 | Q4 2017 | 1 |
ACAD | ACADIA PHARMACEUTICALS... | 1 | 1 | 1.27% | 1.27% | 1.27% | Q1 2016 | Q1 2016 | 1 |
RIGL | RIGEL PHARMACEUTICALS INC | 1 | 1 | 1.26% | 1.26% | 1.26% | Q1 2018 | Q1 2018 | 1 |
MCK | MCKESSON CORP | 1 | 1 | 1.25% | 1.25% | 1.25% | Q1 2021 | Q1 2021 | 1 |
ADMS | ADAMAS PHARMACEUTICALS... | 1 | 1 | 1.24% | 1.24% | 1.24% | Q3 2017 | Q3 2017 | 1 |
ALR | ALERE INC | 1 | 1 | 1.18% | 1.18% | 1.18% | Q3 2016 | Q3 2016 | 1 |
ISHARES TR | 1 | 1 | 1.16% | 1.16% | 1.16% | Q1 2022 | Q1 2022 | 1 | |
NTUS | NATUS MED INC DEL | 1 | 1 | 1.14% | 1.14% | 1.14% | Q1 2018 | Q1 2018 | 1 |
THOR | THORATEC CORP | 1 | 1 | 1.14% | 1.14% | 1.14% | Q2 2015 | Q2 2015 | 1 |
RMD | RESMED INC | 1 | 1 | 1.13% | 1.13% | 1.13% | Q4 2015 | Q4 2015 | 1 |
SYNH | SYNEOS HEALTH INC | 1 | 1 | 1.13% | 1.13% | 1.13% | Q2 2018 | Q2 2018 | 1 |
CLVS | CLOVIS ONCOLGY INC | 1 | 1 | 1.12% | 1.12% | 1.12% | Q2 2017 | Q2 2017 | 1 |
RESMED INC | 1 | 1 | 1.11% | 1.11% | 1.11% | Q1 2023 | Q1 2023 | 1 | |
ESPR | ESPERION THERAPEUTICS ... | 1 | 1 | 1.10% | 1.10% | 1.10% | Q2 2015 | Q2 2015 | 1 |
DHR | DANAHER CORP DEL | 1 | 1 | 1.10% | 1.10% | 1.10% | Q1 2015 | Q1 2015 | 1 |
XENT | INTERSECT ENT INC | 1 | 1 | 1.05% | 1.05% | 1.05% | Q2 2018 | Q2 2018 | 1 |
LPNT | LIFEPOINT HEALTH INC | 1 | 1 | 1.04% | 1.04% | 1.04% | Q4 2016 | Q4 2016 | 1 |
INTUITIVE SURGICAL INC | 1 | 1 | 1.03% | 1.03% | 1.03% | Q1 2023 | Q1 2023 | 1 | |
THC | TENET HEALTHCARE CORP | 1 | 1 | 1.03% | 1.03% | 1.03% | Q3 2016 | Q3 2016 | 1 |
RMD | RESMED INC | 1 | 1 | 1.03% | 1.03% | 1.03% | Q4 2014 | Q4 2014 | 1 |
COMPASS PATHWAYS PLC | 1 | 1 | 1.03% | 1.03% | 1.03% | Q3 2021 | Q3 2021 | 1 | |
EWA | ISHARES | 1 | 1 | 1.02% | 1.02% | 1.02% | Q3 2015 | Q3 2015 | 1 |
NABRIVA THERAPEUTICS PLC | 1 | 1 | 1.02% | 1.02% | 1.02% | Q3 2017 | Q3 2017 | 1 | |
STAA | STAAR SURGICAL CO | 1 | 1 | 1.01% | 1.01% | 1.01% | Q4 2019 | Q4 2019 | 1 |
SMH | VANECK VECTORS ETF TR | 1 | 1 | 1.01% | 1.01% | 1.01% | Q3 2018 | Q3 2018 | 1 |
BAXTER INTL INC | 1 | 1 | 1.01% | 1.01% | 1.01% | Q1 2022 | Q1 2022 | 1 | |
ONCE | SPARK THERAPEUTICS INC | 1 | 1 | 0.98% | 0.98% | 0.98% | Q3 2017 | Q3 2017 | 1 |
MR | MINDRAY MEDICAL INTL LTD | 1 | 1 | 0.97% | 0.97% | 0.97% | Q4 2014 | Q4 2014 | 1 |
AERI | AERIE PHARMACEUTICALS INC | 1 | 1 | 0.97% | 0.97% | 0.97% | Q3 2018 | Q3 2018 | 1 |
STJ | ST JUDE MED INC | 1 | 1 | 0.96% | 0.96% | 0.96% | Q4 2014 | Q4 2014 | 1 |
SILK RD MED INC | 1 | 1 | 0.95% | 0.95% | 0.95% | Q2 2023 | Q2 2023 | 1 | |
CSII | CARDIOVASCULAR SYS INC... | 1 | 1 | 0.93% | 0.93% | 0.93% | Q4 2019 | Q4 2019 | 1 |
MYL | MYLAN N V | 1 | 1 | 0.93% | 0.93% | 0.93% | Q1 2016 | Q1 2016 | 1 |
CELG | CELGENE CORP | 1 | 1 | 0.93% | 0.93% | 0.93% | Q4 2014 | Q4 2014 | 1 |
VNDA | VANDA PHARMACEUTICALS INC | 1 | 1 | 0.92% | 0.92% | 0.92% | Q4 2014 | Q4 2014 | 1 |
HCA | HCA HEALTHCARE INC | 1 | 1 | 0.92% | 0.92% | 0.92% | Q4 2017 | Q4 2017 | 1 |
OFIX | ORTHOFIX INTL N V | 1 | 1 | 0.91% | 0.91% | 0.91% | Q3 2016 | Q3 2016 | 1 |
GBT | GLOBAL BLOOD THERAPEUT... | 1 | 1 | 0.91% | 0.91% | 0.91% | Q2 2018 | Q2 2018 | 1 |
MMSI | MERIT MED SYS INC | 1 | 1 | 0.90% | 0.90% | 0.90% | Q2 2019 | Q2 2019 | 1 |
PENUMBRA INC | 1 | 1 | 0.90% | 0.90% | 0.90% | Q2 2022 | Q2 2022 | 1 | |
FPRX | FIVE PRIME THERAPEUTIC... | 1 | 1 | 0.90% | 0.90% | 0.90% | Q3 2017 | Q3 2017 | 1 |
AXGN | AXOGEN INC | 1 | 1 | 0.90% | 0.90% | 0.90% | Q1 2019 | Q1 2019 | 1 |
BRISTOL-MYERS SQUIBB CO | 1 | 1 | 0.89% | 0.89% | 0.89% | Q2 2022 | Q2 2022 | 1 | |
RARE | ULTRAGENYX PHARMACEUTI... | 1 | 1 | 0.86% | 0.86% | 0.86% | Q3 2016 | Q3 2016 | 1 |
MDCO | MEDICINES CO | 1 | 1 | 0.85% | 0.85% | 0.85% | Q3 2019 | Q3 2019 | 1 |
MYGN | MYRIAD GENETICS INC | 1 | 1 | 0.84% | 0.84% | 0.84% | Q2 2019 | Q2 2019 | 1 |
GLAUKOS CORP | 1 | 1 | 0.84% | 0.84% | 0.84% | Q1 2023 | Q1 2023 | 1 | |
AVGR | AVINGER INC | 1 | 1 | 0.83% | 0.83% | 0.83% | Q3 2016 | Q3 2016 | 1 |
AXONICS INC | 1 | 1 | 0.83% | 0.83% | 0.83% | Q1 2023 | Q1 2023 | 1 | |
JETS | ETF SER SOLUTIONS | 1 | 1 | 0.81% | 0.81% | 0.81% | Q4 2020 | Q4 2020 | 1 |
HANGER INC | 1 | 1 | 0.81% | 0.81% | 0.81% | Q4 2014 | Q4 2014 | 1 | |
TELEFLEX INCORPORATED | 1 | 1 | 0.77% | 0.77% | 0.77% | Q1 2023 | Q1 2023 | 1 | |
CARA | CARA THERAPEUTICS INC | 1 | 1 | 0.77% | 0.77% | 0.77% | Q2 2018 | Q2 2018 | 1 |
ITCI | INTRA CELLULAR THERAPI... | 1 | 1 | 0.77% | 0.77% | 0.77% | Q3 2018 | Q3 2018 | 1 |
RAD | RITE AID CORP | 1 | 1 | 0.76% | 0.76% | 0.76% | Q4 2014 | Q4 2014 | 1 |
MTUM | ISHARES TR | 1 | 1 | 0.76% | 0.76% | 0.76% | Q1 2020 | Q1 2020 | 1 |
ALIGN TECHNOLOGY INC | 1 | 1 | 0.76% | 0.76% | 0.76% | Q2 2022 | Q2 2022 | 1 | |
BOSTON BEER INC | 1 | 1 | 0.75% | 0.75% | 0.75% | Q3 2022 | Q3 2022 | 1 | |
TSRO | TESARO INC | 1 | 1 | 0.73% | 0.73% | 0.73% | Q2 2017 | Q2 2017 | 1 |
ABBOTT LABS | 1 | 1 | 0.72% | 0.72% | 0.72% | Q2 2021 | Q2 2021 | 1 | |
HTWR | HEARTWARE INTL INC | 1 | 1 | 0.71% | 0.71% | 0.71% | Q1 2016 | Q1 2016 | 1 |
STAAR SURGICAL CO | 1 | 1 | 0.71% | 0.71% | 0.71% | Q1 2023 | Q1 2023 | 1 | |
QSII | QUALITY SYS INC | 1 | 1 | 0.70% | 0.70% | 0.70% | Q4 2016 | Q4 2016 | 1 |
AGILENT TECHNOLOGIES INC | 1 | 1 | 0.70% | 0.70% | 0.70% | Q1 2023 | Q1 2023 | 1 | |
MDVN | MEDIVATION INC | 1 | 1 | 0.70% | 0.70% | 0.70% | Q4 2014 | Q4 2014 | 1 |
NVTRQ | NUVECTRA CORP | 1 | 1 | 0.69% | 0.69% | 0.69% | Q3 2018 | Q3 2018 | 1 |
BIONTECH SE | 1 | 1 | 0.69% | 0.69% | 0.69% | Q2 2022 | Q2 2022 | 1 | |
ILMN | ILLUMINA INC | 1 | 1 | 0.68% | 0.68% | 0.68% | Q1 2021 | Q1 2021 | 1 |
PERKINELMER INC | 1 | 1 | 0.67% | 0.67% | 0.67% | Q1 2023 | Q1 2023 | 1 | |
KITE | KITE PHARMA INC | 1 | 1 | 0.67% | 0.67% | 0.67% | Q3 2016 | Q3 2016 | 1 |
ALIGN TECHNOLOGY INC | 1 | 1 | 0.67% | 0.67% | 0.67% | Q1 2023 | Q1 2023 | 1 | |
MRTX | MIRATI THERAPEUTICS INC | 1 | 1 | 0.67% | 0.67% | 0.67% | Q3 2019 | Q3 2019 | 1 |
CTLT | CATALENT INC | 1 | 1 | 0.66% | 0.66% | 0.66% | Q2 2019 | Q2 2019 | 1 |
EDWARDS LIFESCIENCES CORP | 1 | 1 | 0.66% | 0.66% | 0.66% | Q3 2023 | Q3 2023 | 1 | |
ZGNX | ZOGENIX INC | 1 | 1 | 0.64% | 0.64% | 0.64% | Q2 2018 | Q2 2018 | 1 |
GKOS | GLAUKOS CORP | 1 | 1 | 0.63% | 0.63% | 0.63% | Q4 2019 | Q4 2019 | 1 |
CORT | CORCEPT THERAPEUTICS INC | 1 | 1 | 0.63% | 0.63% | 0.63% | Q2 2018 | Q2 2018 | 1 |
SDC | SMILEDIRECTCLUB INC | 1 | 1 | 0.63% | 0.63% | 0.63% | Q4 2019 | Q4 2019 | 1 |
INTEGRA LIFESCIENCES H... | 1 | 1 | 0.63% | 0.63% | 0.63% | Q1 2023 | Q1 2023 | 1 | |
HYH | HALYARD HEALTH INC | 1 | 1 | 0.63% | 0.63% | 0.63% | Q4 2015 | Q4 2015 | 1 |
TENET HEALTHCARE CORP | 1 | 1 | 0.62% | 0.62% | 0.62% | Q3 2023 | Q3 2023 | 1 | |
MD | MEDNAX INC | 1 | 1 | 0.61% | 0.61% | 0.61% | Q4 2014 | Q4 2014 | 1 |
ALCON AG | 1 | 1 | 0.61% | 0.61% | 0.61% | Q1 2023 | Q1 2023 | 1 | |
INSULET CORP | 1 | 1 | 0.60% | 0.60% | 0.60% | Q3 2023 | Q3 2023 | 1 | |
AXGN | AXOGEN INC | 1 | 1 | 0.60% | 0.60% | 0.60% | Q2 2019 | Q2 2019 | 1 |
AVRO | AVROBIO INC | 1 | 1 | 0.60% | 0.60% | 0.60% | Q2 2018 | Q2 2018 | 1 |
EPZM | EPIZYME INC | 1 | 1 | 0.60% | 0.60% | 0.60% | Q2 2017 | Q2 2017 | 1 |
COOPER COS INC | 1 | 1 | 0.60% | 0.60% | 0.60% | Q4 2021 | Q4 2021 | 1 | |
NVTA | INVITAE CORP | 1 | 1 | 0.60% | 0.60% | 0.60% | Q2 2020 | Q2 2020 | 1 |
DENTSPLY SIRONA INC | 1 | 1 | 0.59% | 0.59% | 0.59% | Q1 2022 | Q1 2022 | 1 | |
CANOPY GROWTH CORP | 1 | 1 | 0.58% | 0.58% | 0.58% | Q2 2022 | Q2 2022 | 1 | |
IONS | IONIS PHARMACEUTICALS INC | 1 | 1 | 0.58% | 0.58% | 0.58% | Q1 2019 | Q1 2019 | 1 |
PCRX | PACIRA PHARMACEUTICALS... | 1 | 1 | 0.57% | 0.57% | 0.57% | Q1 2017 | Q1 2017 | 1 |
ANGO | ANGIODYNAMICS INC | 1 | 1 | 0.56% | 0.56% | 0.56% | Q1 2016 | Q1 2016 | 1 |
ISRG | INTUITIVE SURGICAL INC | 1 | 1 | 0.55% | 0.55% | 0.55% | Q3 2020 | Q3 2020 | 1 |
CHRS | COHERUS BIOSCIENCES INC | 1 | 1 | 0.55% | 0.55% | 0.55% | Q2 2018 | Q2 2018 | 1 |
AVNR | AVANIR PHARMACEUTICALS... | 1 | 1 | 0.55% | 0.55% | 0.55% | Q4 2014 | Q4 2014 | 1 |
ALGN | ALIGN TECHNOLOGY INC | 1 | 1 | 0.54% | 0.54% | 0.54% | Q1 2021 | Q1 2021 | 1 |
MADRIGAL PHARMACEUTICA... | 1 | 1 | 0.54% | 0.54% | 0.54% | Q4 2022 | Q4 2022 | 1 | |
ARGX | ARGENX SE | 1 | 1 | 0.54% | 0.54% | 0.54% | Q4 2017 | Q4 2017 | 1 |
IRWD | IRONWOOD PHARMACEUTICA... | 1 | 1 | 0.54% | 0.54% | 0.54% | Q2 2015 | Q2 2015 | 1 |
IPXL | IMPAX LABORATORIES INC | 1 | 1 | 0.53% | 0.53% | 0.53% | Q2 2015 | Q2 2015 | 1 |
ABBVIE INC | 1 | 1 | 0.53% | 0.53% | 0.53% | Q1 2022 | Q1 2022 | 1 | |
OFIX | ORTHOFIX MED INC | 1 | 1 | 0.52% | 0.52% | 0.52% | Q4 2018 | Q4 2018 | 1 |
VAREX IMAGING CORP | 1 | 1 | 0.52% | 0.52% | 0.52% | Q1 2022 | Q1 2022 | 1 | |
KONINKLIJKE PHILIPS N V | 1 | 1 | 0.51% | 0.51% | 0.51% | Q1 2023 | Q1 2023 | 1 | |
COOPER COS INC | 1 | 1 | 0.50% | 0.50% | 0.50% | Q1 2022 | Q1 2022 | 1 | |
AERI | AERIE PHARMACEUTICALS INC | 1 | 1 | 0.50% | 0.50% | 0.50% | Q3 2017 | Q3 2017 | 1 |
SGNT | SAGENT PHARMACEUTICALS... | 1 | 1 | 0.50% | 0.50% | 0.50% | Q1 2016 | Q1 2016 | 1 |
MRTX | MIRATI THERAPEUTICS INC | 1 | 1 | 0.50% | 0.50% | 0.50% | Q3 2018 | Q3 2018 | 1 |
MSOS | ADVISORSHARES TR | 1 | 1 | 0.49% | 0.49% | 0.49% | Q3 2023 | Q3 2023 | 1 |
CANO | CANO HEALTH INC | 1 | 1 | 0.49% | 0.49% | 0.49% | Q3 2021 | Q3 2021 | 1 |
MR | MINDRAY MEDICAL INTL LTD | 1 | 1 | 0.49% | 0.49% | 0.49% | Q4 2014 | Q4 2014 | 1 |
ARRY | ARRAY BIOPHARMA INC | 1 | 1 | 0.48% | 0.48% | 0.48% | Q1 2018 | Q1 2018 | 1 |
PENUMBRA INC | 1 | 1 | 0.48% | 0.48% | 0.48% | Q4 2022 | Q4 2022 | 1 | |
REPLIGEN CORP | 1 | 1 | 0.48% | 0.48% | 0.48% | Q1 2023 | Q1 2023 | 1 | |
ARK ETF TR | 1 | 1 | 0.46% | 0.46% | 0.46% | Q2 2022 | Q2 2022 | 1 | |
SOUTHWEST AIRLS CO | 1 | 1 | 0.46% | 0.46% | 0.46% | Q4 2021 | Q4 2021 | 1 | |
ABM | ABM INDS INC | 1 | 1 | 0.46% | 0.46% | 0.46% | Q2 2020 | Q2 2020 | 1 |
TDOC | TELADOC HEALTH INC | 1 | 1 | 0.46% | 0.46% | 0.46% | Q1 2019 | Q1 2019 | 1 |
NTLA | INTELLIA THERAPEUTICS INC | 1 | 1 | 0.45% | 0.45% | 0.45% | Q1 2021 | Q1 2021 | 1 |
MJ | ETF MANAGERS TR | 1 | 1 | 0.45% | 0.45% | 0.45% | Q4 2019 | Q4 2019 | 1 |
PTCT | PTC THERAPEUTICS INC | 1 | 1 | 0.45% | 0.45% | 0.45% | Q1 2019 | Q1 2019 | 1 |
AKRXQ | AKORN INC | 1 | 1 | 0.45% | 0.45% | 0.45% | Q2 2018 | Q2 2018 | 1 |
ALKS | ALKERMES PLC | 1 | 1 | 0.45% | 0.45% | 0.45% | Q3 2018 | Q3 2018 | 1 |
VEEVA SYS INC | 1 | 1 | 0.44% | 0.44% | 0.44% | Q3 2021 | Q3 2021 | 1 | |
LIVN | LIVANOVA PLC | 1 | 1 | 0.44% | 0.44% | 0.44% | Q2 2019 | Q2 2019 | 1 |
NEOS | NEOS THERAPEUTICS INC | 1 | 1 | 0.44% | 0.44% | 0.44% | Q2 2017 | Q2 2017 | 1 |
EAR | EARGO INC | 1 | 1 | 0.43% | 0.43% | 0.43% | Q1 2021 | Q1 2021 | 1 |
THOR | THORATEC CORP | 1 | 1 | 0.43% | 0.43% | 0.43% | Q1 2015 | Q1 2015 | 1 |
ISHARES TR | 1 | 1 | 0.42% | 0.42% | 0.42% | Q1 2022 | Q1 2022 | 1 | |
BDSI | BIODELIVERY SCIENCES I... | 1 | 1 | 0.42% | 0.42% | 0.42% | Q1 2015 | Q1 2015 | 1 |
SPECTRUM PHARMACEUTICA... | 1 | 1 | 0.42% | 0.42% | 0.42% | Q3 2017 | Q3 2017 | 1 | |
ENVISTA HOLDINGS CORPO... | 1 | 1 | 0.41% | 0.41% | 0.41% | Q1 2022 | Q1 2022 | 1 | |
ABCM | ABCAM PLC | 1 | 1 | 0.41% | 0.41% | 0.41% | Q2 2023 | Q2 2023 | 1 |
PBH | PRESTIGE CONSMR HEALTH... | 1 | 1 | 0.40% | 0.40% | 0.40% | Q3 2018 | Q3 2018 | 1 |
XRAY | DENTSPLY SIRONA INC | 1 | 1 | 0.39% | 0.39% | 0.39% | Q4 2020 | Q4 2020 | 1 |
LANTHEUS HLDGS INC | 1 | 1 | 0.39% | 0.39% | 0.39% | Q1 2023 | Q1 2023 | 1 | |
MMSI | MERIT MED SYS INC | 1 | 1 | 0.39% | 0.39% | 0.39% | Q4 2019 | Q4 2019 | 1 |
VCRA | VOCERA COMMUNICATIONS INC | 1 | 1 | 0.39% | 0.39% | 0.39% | Q3 2018 | Q3 2018 | 1 |
ABBV | ABBVIE INC | 1 | 1 | 0.39% | 0.39% | 0.39% | Q4 2020 | Q4 2020 | 1 |
ONCOCYTE CORP | 1 | 1 | 0.39% | 0.39% | 0.39% | Q3 2023 | Q3 2023 | 1 | |
RPTP | RAPTOR PHARMACEUTICAL ... | 1 | 1 | 0.39% | 0.39% | 0.39% | Q4 2014 | Q4 2014 | 1 |
VKTX | VIKING THERAPEUTICS INC | 1 | 1 | 0.38% | 0.38% | 0.38% | Q2 2018 | Q2 2018 | 1 |
CHARLES RIV LABS INTL INC | 1 | 1 | 0.38% | 0.38% | 0.38% | Q2 2023 | Q2 2023 | 1 | |
QIAGEN NV | 1 | 1 | 0.38% | 0.38% | 0.38% | Q2 2021 | Q2 2021 | 1 | |
MDRX | ALLSCRIPTS HEALTHCARE ... | 1 | 1 | 0.37% | 0.37% | 0.37% | Q4 2018 | Q4 2018 | 1 |
CEREVEL THERAPEUTICS H... | 1 | 1 | 0.37% | 0.37% | 0.37% | Q2 2022 | Q2 2022 | 1 | |
PFIZER INC | 1 | 1 | 0.37% | 0.37% | 0.37% | Q2 2021 | Q2 2021 | 1 | |
BEAT | BIOTELEMETRY INC | 1 | 1 | 0.37% | 0.37% | 0.37% | Q2 2019 | Q2 2019 | 1 |
MRNA | MODERNA INC | 1 | 1 | 0.36% | 0.36% | 0.36% | Q3 2020 | Q3 2020 | 1 |
NEOGENOMICS INC | 1 | 1 | 0.36% | 0.36% | 0.36% | Q4 2021 | Q4 2021 | 1 | |
TWST | TWIST BIOSCIENCE CORP | 1 | 1 | 0.36% | 0.36% | 0.36% | Q4 2020 | Q4 2020 | 1 |
AVANTOR INC | 1 | 1 | 0.36% | 0.36% | 0.36% | Q1 2022 | Q1 2022 | 1 | |
HRC | HILL ROM HLDGS INC | 1 | 1 | 0.36% | 0.36% | 0.36% | Q4 2020 | Q4 2020 | 1 |
LSF | LAIRD SUPERFOOD INC | 1 | 1 | 0.36% | 0.36% | 0.36% | Q3 2020 | Q3 2020 | 1 |
ANTM | ANTHEM INC | 1 | 1 | 0.35% | 0.35% | 0.35% | Q4 2020 | Q4 2020 | 1 |
ACHN | ACHILLION PHARMACEUTIC... | 1 | 1 | 0.35% | 0.35% | 0.35% | Q3 2019 | Q3 2019 | 1 |
IMMU | IMMUNOMEDICS INC | 1 | 1 | 0.35% | 0.35% | 0.35% | Q2 2020 | Q2 2020 | 1 |
HZNP | HORIZON THERAPEUTICS P... | 1 | 1 | 0.35% | 0.35% | 0.35% | Q4 2019 | Q4 2019 | 1 |
FATE | FATE THERAPEUTICS INC | 1 | 1 | 0.34% | 0.34% | 0.34% | Q1 2018 | Q1 2018 | 1 |
ACCELERON PHARMA INC | 1 | 1 | 0.34% | 0.34% | 0.34% | Q3 2021 | Q3 2021 | 1 | |
MMM | 3M CO | 1 | 1 | 0.33% | 0.33% | 0.33% | Q3 2020 | Q3 2020 | 1 |
IART | INTEGRA LIFESCIENCES H... | 1 | 1 | 0.33% | 0.33% | 0.33% | Q1 2021 | Q1 2021 | 1 |
AMGEN INC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q3 2021 | Q3 2021 | 1 | |
STE | STERIS PLC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q4 2020 | Q4 2020 | 1 |
CMD | CANTEL MED CORP | 1 | 1 | 0.32% | 0.32% | 0.32% | Q3 2019 | Q3 2019 | 1 |
GILEAD SCIENCES INC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q3 2021 | Q3 2021 | 1 | |
TECH | BIO-TECHNE CORP | 1 | 1 | 0.32% | 0.32% | 0.32% | Q3 2020 | Q3 2020 | 1 |
CRY | CRYOLIFE INC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q2 2019 | Q2 2019 | 1 |
ATEC | ALPHATEC HLDGS INC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q2 2023 | Q2 2023 | 1 |
ACOR | ACORDA THERAPEUTICS INC | 1 | 1 | 0.31% | 0.31% | 0.31% | Q4 2017 | Q4 2017 | 1 |
TALK | TALKSPACE INC | 1 | 1 | 0.31% | 0.31% | 0.31% | Q2 2021 | Q2 2021 | 1 |
SELECT SECTOR SPDR TR | 1 | 1 | 0.31% | 0.31% | 0.31% | Q1 2022 | Q1 2022 | 1 | |
ABLX | ABLYNX NV | 1 | 1 | 0.31% | 0.31% | 0.31% | Q4 2017 | Q4 2017 | 1 |
TRS | TRIMAS CORP | 1 | 1 | 0.31% | 0.31% | 0.31% | Q2 2020 | Q2 2020 | 1 |
ZIMMER BIOMET HOLDINGS... | 1 | 1 | 0.30% | 0.30% | 0.30% | Q2 2022 | Q2 2022 | 1 | |
BHVN | BIOHAVEN PHARMACTL HLD... | 1 | 1 | 0.30% | 0.30% | 0.30% | Q1 2018 | Q1 2018 | 1 |
CSTL | CASTLE BIOSCIENCES INC | 1 | 1 | 0.30% | 0.30% | 0.30% | Q1 2021 | Q1 2021 | 1 |
FLGT | FULGENT GENETICS INC | 1 | 1 | 0.30% | 0.30% | 0.30% | Q1 2021 | Q1 2021 | 1 |
DOCGO INC | 1 | 1 | 0.30% | 0.30% | 0.30% | Q3 2023 | Q3 2023 | 1 | |
ATAI LIFE SCIENCES NV | 1 | 1 | 0.29% | 0.29% | 0.29% | Q3 2021 | Q3 2021 | 1 | |
STERIS PLC | 1 | 1 | 0.29% | 0.29% | 0.29% | Q3 2022 | Q3 2022 | 1 | |
SGFY | SIGNIFY HEALTH INC | 1 | 1 | 0.29% | 0.29% | 0.29% | Q1 2021 | Q1 2021 | 1 |
JNCE | JOUNCE THERAPEUTICS INC | 1 | 1 | 0.29% | 0.29% | 0.29% | Q1 2018 | Q1 2018 | 1 |
TRANSMEDICS GROUP INC | 1 | 1 | 0.29% | 0.29% | 0.29% | Q4 2022 | Q4 2022 | 1 | |
MIRATI THERAPEUTICS INC | 1 | 1 | 0.29% | 0.29% | 0.29% | Q4 2022 | Q4 2022 | 1 | |
SYNEOS HEALTH INC | 1 | 1 | 0.28% | 0.28% | 0.28% | Q4 2022 | Q4 2022 | 1 | |
NEVRO CORP | 1 | 1 | 0.28% | 0.28% | 0.28% | Q3 2021 | Q3 2021 | 1 | |
DELTA AIR LINES INC DEL | 1 | 1 | 0.28% | 0.28% | 0.28% | Q4 2021 | Q4 2021 | 1 | |
MODERNA INC | 1 | 1 | 0.28% | 0.28% | 0.28% | Q1 2022 | Q1 2022 | 1 | |
TANDEM DIABETES CARE INC | 1 | 1 | 0.28% | 0.28% | 0.28% | Q3 2022 | Q3 2022 | 1 | |
CPXX | CELATOR PHARMACEUTICAL... | 1 | 1 | 0.28% | 0.28% | 0.28% | Q1 2016 | Q1 2016 | 1 |
GERN | GERON CORP | 1 | 1 | 0.28% | 0.28% | 0.28% | Q2 2018 | Q2 2018 | 1 |
HZNP | HORIZON PHARMA PLC | 1 | 1 | 0.28% | 0.28% | 0.28% | Q3 2016 | Q3 2016 | 1 |
MYOK | MYOKARDIA INC | 1 | 1 | 0.27% | 0.27% | 0.27% | Q2 2020 | Q2 2020 | 1 |
ZY | ZYMERGEN INC | 1 | 1 | 0.27% | 0.27% | 0.27% | Q2 2021 | Q2 2021 | 1 |
GINKGO BIOWORKS HOLDIN... | 1 | 1 | 0.26% | 0.26% | 0.26% | Q3 2021 | Q3 2021 | 1 | |
IOVA | IOVANCE BIOTHERAPEUTIC... | 1 | 1 | 0.26% | 0.26% | 0.26% | Q4 2019 | Q4 2019 | 1 |
OMEGA HEALTHCARE INVS INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q4 2021 | Q4 2021 | 1 | |
INTEC PHARMA LTD JERUS... | 1 | 1 | 0.26% | 0.26% | 0.26% | Q3 2017 | Q3 2017 | 1 | |
NEO | NEOGENOMICS INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q3 2021 | Q3 2021 | 1 |
INTUITIVE SURGICAL INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q4 2021 | Q4 2021 | 1 | |
WEST PHARMACEUTICAL SV... | 1 | 1 | 0.26% | 0.26% | 0.26% | Q3 2021 | Q3 2021 | 1 | |
ADMA | ADMA BIOLOGICS INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q1 2019 | Q1 2019 | 1 |
SIGNIFY HEALTH INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q4 2021 | Q4 2021 | 1 | |
IMUX | IMMUNIC INC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q1 2022 | Q1 2022 | 1 |
BSTC | BIOSPECIFICS TECHNOLOG... | 1 | 1 | 0.25% | 0.25% | 0.25% | Q3 2018 | Q3 2018 | 1 |
CRL | CHARLES RIV LABS INTL INC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q1 2021 | Q1 2021 | 1 |
MASIMO CORP | 1 | 1 | 0.24% | 0.24% | 0.24% | Q3 2022 | Q3 2022 | 1 | |
NANO X IMAGING LTD | 1 | 1 | 0.24% | 0.24% | 0.24% | Q2 2023 | Q2 2023 | 1 | |
SAGE | SAGE THERAPEUTICS INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q3 2019 | Q3 2019 | 1 |
AAL | AMERICAN AIRLS GROUP INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q3 2020 | Q3 2020 | 1 |
WALGREENS BOOTS ALLIAN... | 1 | 1 | 0.23% | 0.23% | 0.23% | Q1 2022 | Q1 2022 | 1 | |
ABBVIE INC | 1 | 1 | 0.23% | 0.23% | 0.23% | Q2 2021 | Q2 2021 | 1 | |
BNR | BURNING ROCK BIOTECH LTD | 1 | 1 | 0.23% | 0.23% | 0.23% | Q3 2020 | Q3 2020 | 1 |
TRUPANION INC | 1 | 1 | 0.23% | 0.23% | 0.23% | Q1 2023 | Q1 2023 | 1 | |
HEC | HUDSON EXECUTIVE INVT ... | 1 | 1 | 0.23% | 0.23% | 0.23% | Q1 2021 | Q1 2021 | 1 |
AZENTA INC | 1 | 1 | 0.23% | 0.23% | 0.23% | Q1 2022 | Q1 2022 | 1 | |
GRTS | GRITSTONE ONCOLOGY INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q3 2018 | Q3 2018 | 1 |
XNCR | XENCOR INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q2 2018 | Q2 2018 | 1 |
LIVANOVA PLC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q1 2023 | Q1 2023 | 1 | |
STAAR SURGICAL CO | 1 | 1 | 0.22% | 0.22% | 0.22% | Q1 2022 | Q1 2022 | 1 | |
KRTX | KARUNA THERAPEUTICS INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q2 2022 | Q2 2022 | 1 |
CYRX | CRYOPORT INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q1 2021 | Q1 2021 | 1 |
CVRX | CVRX INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q2 2021 | Q2 2021 | 1 |
AVGR | AVINGER INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q3 2016 | Q3 2016 | 1 |
SNY | SANOFI | 1 | 1 | 0.22% | 0.22% | 0.22% | Q3 2022 | Q3 2022 | 1 |
CLDN | CELLADON CORP | 1 | 1 | 0.22% | 0.22% | 0.22% | Q1 2015 | Q1 2015 | 1 |
MODERNA INC | 1 | 1 | 0.21% | 0.21% | 0.21% | Q4 2021 | Q4 2021 | 1 | |
IART | INTEGRA LIFESCIENCES H... | 1 | 1 | 0.21% | 0.21% | 0.21% | Q2 2019 | Q2 2019 | 1 |
EVOLENT HEALTH INC | 1 | 1 | 0.21% | 0.21% | 0.21% | Q3 2021 | Q3 2021 | 1 | |
CANOPY GROWTH CORP | 1 | 1 | 0.21% | 0.21% | 0.21% | Q4 2022 | Q4 2022 | 1 | |
ABM INDS INC | 1 | 1 | 0.21% | 0.21% | 0.21% | Q2 2021 | Q2 2021 | 1 | |
CLOVER HEALTH INVESTME... | 1 | 1 | 0.21% | 0.21% | 0.21% | Q2 2021 | Q2 2021 | 1 | |
LGVW | LONGVIEW ACQUISITION CORP | 1 | 1 | 0.20% | 0.20% | 0.20% | Q4 2020 | Q4 2020 | 1 |
NUVA | NUVASIVE INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q2 2020 | Q2 2020 | 1 |
PRTA | PROTHENA CORP PLC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q4 2022 | Q4 2022 | 1 |
DARIOHEALTH CORP | 1 | 1 | 0.20% | 0.20% | 0.20% | Q1 2021 | Q1 2021 | 1 | |
PTLA | PORTOLA PHARMACEUTICAL... | 1 | 1 | 0.20% | 0.20% | 0.20% | Q4 2018 | Q4 2018 | 1 |
OSUR | ORASURE TECHNOLOGIES INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q3 2020 | Q3 2020 | 1 |
GILEAD SCIENCES INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q1 2022 | Q1 2022 | 1 | |
CABA | CABALETTA BIO INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q4 2019 | Q4 2019 | 1 |
NVCR | NOVOCURE LTD | 1 | 1 | 0.19% | 0.19% | 0.19% | Q4 2022 | Q4 2022 | 1 |
MRNA | MODERNA INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q1 2021 | Q1 2021 | 1 |
ETF SER SOLUTIONS | 1 | 1 | 0.19% | 0.19% | 0.19% | Q4 2021 | Q4 2021 | 1 | |
KARUNA THERAPEUTICS INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q2 2022 | Q2 2022 | 1 | |
BEAM THERAPEUTICS INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q1 2022 | Q1 2022 | 1 | |
INNV | INNOVAGE HLDG CORP | 1 | 1 | 0.18% | 0.18% | 0.18% | Q1 2021 | Q1 2021 | 1 |
HGEN | HUMANIGEN INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q1 2021 | Q1 2021 | 1 |
AXNX | AXONICS MODULATION TEC... | 1 | 1 | 0.18% | 0.18% | 0.18% | Q4 2020 | Q4 2020 | 1 |
ZYNE | ZYNERBA PHARMACEUTICAL... | 1 | 1 | 0.18% | 0.18% | 0.18% | Q1 2017 | Q1 2017 | 1 |
TNDM | TANDEM DIABETES CARE INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q1 2021 | Q1 2021 | 1 |
SPPI | SPECTRUM PHARMACEUTICA... | 1 | 1 | 0.18% | 0.18% | 0.18% | Q3 2018 | Q3 2018 | 1 |
FIBROGEN INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q2 2021 | Q2 2021 | 1 | |
MERCK & CO INC | 1 | 1 | 0.17% | 0.17% | 0.17% | Q4 2021 | Q4 2021 | 1 | |
SNDX | SYNDAX PHARMACEUTICALS... | 1 | 1 | 0.17% | 0.17% | 0.17% | Q3 2018 | Q3 2018 | 1 |
PTC THERAPEUTICS INC | 1 | 1 | 0.17% | 0.17% | 0.17% | Q2 2022 | Q2 2022 | 1 | |
NPCE | NEUROPACE INC | 1 | 1 | 0.17% | 0.17% | 0.17% | Q2 2021 | Q2 2021 | 1 |
CORT | CORCEPT THERAPEUTICS INC | 1 | 1 | 0.17% | 0.17% | 0.17% | Q3 2020 | Q3 2020 | 1 |
RCL | ROYAL CARIBBEAN GROUP | 1 | 1 | 0.17% | 0.17% | 0.17% | Q3 2020 | Q3 2020 | 1 |
AXONICS INC | 1 | 1 | 0.17% | 0.17% | 0.17% | Q1 2023 | Q1 2023 | 1 | |
APELLIS PHARMACEUTICAL... | 1 | 1 | 0.16% | 0.16% | 0.16% | Q1 2022 | Q1 2022 | 1 | |
CMLTU | CM LIFE SCIENCES III INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2021 | Q2 2021 | 1 |
DRNA | DICERNA PHARMACEUTICAL... | 1 | 1 | 0.16% | 0.16% | 0.16% | Q3 2018 | Q3 2018 | 1 |
BVX | BOVIE MEDICAL CORP | 1 | 1 | 0.16% | 0.16% | 0.16% | Q4 2016 | Q4 2016 | 1 |
FIBROGEN INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2021 | Q2 2021 | 1 | |
ELGX | ENDOLOGIX INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q1 2017 | Q1 2017 | 1 |
INTERCEPT PHARMACEUTIC... | 1 | 1 | 0.16% | 0.16% | 0.16% | Q3 2022 | Q3 2022 | 1 | |
HA | HAWAIIAN HOLDINGS INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q4 2020 | Q4 2020 | 1 |
SCMP | SUCAMPO PHARMACEUTICAL... | 1 | 1 | 0.16% | 0.16% | 0.16% | Q1 2015 | Q1 2015 | 1 |
NTRA | NATERA INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q4 2019 | Q4 2019 | 1 |
SOMALOGIC INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2022 | Q2 2022 | 1 | |
C4 THERAPEUTICS INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q1 2022 | Q1 2022 | 1 | |
CELLDEX THERAPEUTICS I... | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2022 | Q2 2022 | 1 | |
KMPH | KEMPHARM INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2018 | Q2 2018 | 1 |
CHEMOCENTRYX INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q3 2021 | Q3 2021 | 1 | |
MEIP | MEI PHARMA INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q3 2017 | Q3 2017 | 1 |
TWIST BIOSCIENCE CORP | 1 | 1 | 0.15% | 0.15% | 0.15% | Q1 2023 | Q1 2023 | 1 | |
TG THERAPEUTICS INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q4 2022 | Q4 2022 | 1 | |
PCVX | VAXCYTE INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q4 2022 | Q4 2022 | 1 |
ROCKET PHARMACEUTICALS... | 1 | 1 | 0.15% | 0.15% | 0.15% | Q4 2022 | Q4 2022 | 1 | |
HAEMONETICS CORP MASS | 1 | 1 | 0.15% | 0.15% | 0.15% | Q3 2021 | Q3 2021 | 1 | |
STE | STERIS PLC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q4 2022 | Q4 2022 | 1 |
DERM | DERMIRA INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q4 2019 | Q4 2019 | 1 |
BAUSCH HEALTH COS INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q2 2022 | Q2 2022 | 1 | |
CMAX | CAREMAX INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q2 2021 | Q2 2021 | 1 |
NEUROCRINE BIOSCIENCES... | 1 | 1 | 0.14% | 0.14% | 0.14% | Q2 2021 | Q2 2021 | 1 | |
OWENS & MINOR INC NEW | 1 | 1 | 0.14% | 0.14% | 0.14% | Q3 2021 | Q3 2021 | 1 | |
DIN | DINE BRANDS GLOBAL INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q3 2020 | Q3 2020 | 1 |
GI | ENDOCHOICE HLDGS INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q4 2015 | Q4 2015 | 1 |
NKTR | NEKTAR THERAPEUTICS | 1 | 1 | 0.14% | 0.14% | 0.14% | Q4 2021 | Q4 2021 | 1 |
CORCEPT THERAPEUTICS INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q2 2021 | Q2 2021 | 1 | |
ALIGN TECHNOLOGY INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q4 2022 | Q4 2022 | 1 | |
VBLT | VASCULAR BIOGENICS LTD | 1 | 1 | 0.14% | 0.14% | 0.14% | Q1 2018 | Q1 2018 | 1 |
CDNA | CAREDX INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q1 2021 | Q1 2021 | 1 |
HGEN | HUMANIGEN INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q1 2021 | Q1 2021 | 1 |
NOVOCURE LTD | 1 | 1 | 0.13% | 0.13% | 0.13% | Q4 2022 | Q4 2022 | 1 | |
DEFINITIVE HEALTHCARE ... | 1 | 1 | 0.13% | 0.13% | 0.13% | Q3 2021 | Q3 2021 | 1 | |
DCPH | DECIPHERA PHARMACEUTIC... | 1 | 1 | 0.13% | 0.13% | 0.13% | Q1 2021 | Q1 2021 | 1 |
GNMK | GENMARK DIAGNOSTICS INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q3 2020 | Q3 2020 | 1 |
IOVANCE BIOTHERAPEUTIC... | 1 | 1 | 0.13% | 0.13% | 0.13% | Q2 2022 | Q2 2022 | 1 | |
PEN | PENUMBRA INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q4 2020 | Q4 2020 | 1 |
LGVWWS | LONGVIEW ACQUISITION CORP | 1 | 1 | 0.13% | 0.13% | 0.13% | Q4 2020 | Q4 2020 | 1 |
COGT | COGENT BIOSCIENCES INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q2 2022 | Q2 2022 | 1 |
GREENLIGHT BIOSCIENCS ... | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2022 | Q1 2022 | 1 | |
YMAB | Y MABS THERAPEUTICS INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q3 2018 | Q3 2018 | 1 |
NKTR | NEKTAR THERAPEUTICS | 1 | 1 | 0.12% | 0.12% | 0.12% | Q4 2020 | Q4 2020 | 1 |
JUNO | JUNO THERAPEUTICS INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q4 2014 | Q4 2014 | 1 |
AXONICS INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q4 2021 | Q4 2021 | 1 | |
SOLY | SOLITON INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2021 | Q1 2021 | 1 |
INBX | INHIBRX INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q4 2022 | Q4 2022 | 1 |
CNST | CONSTELLATION PHARMCET... | 1 | 1 | 0.12% | 0.12% | 0.12% | Q2 2020 | Q2 2020 | 1 |
AMYRIS INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q3 2022 | Q3 2022 | 1 | |
PTC THERAPEUTICS INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q2 2022 | Q2 2022 | 1 | |
MCRB | SERES THERAPEUTICS INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q2 2020 | Q2 2020 | 1 |
MARAVAI LIFESCIENCES H... | 1 | 1 | 0.12% | 0.12% | 0.12% | Q3 2021 | Q3 2021 | 1 | |
INGN | INOGEN INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q4 2018 | Q4 2018 | 1 |
ARYA | ARYA SCIENCES ACQUISIT... | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2021 | Q1 2021 | 1 |
LH | LABORATORY CORP AMER H... | 1 | 1 | 0.11% | 0.11% | 0.11% | Q4 2020 | Q4 2020 | 1 |
VERV | VERVE THERAPEUTICS INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q2 2021 | Q2 2021 | 1 |
MTEM | MOLECULAR TEMPLATES INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q3 2018 | Q3 2018 | 1 |
ENDP | ENDO INTL PLC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q3 2019 | Q3 2019 | 1 |
RVMD | REVOLUTION MEDICINES INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q3 2022 | Q3 2022 | 1 |
NUVALENT INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q4 2022 | Q4 2022 | 1 | |
SOLID BIOSCIENCES INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q1 2023 | Q1 2023 | 1 | |
GLAUKOS CORP | 1 | 1 | 0.11% | 0.11% | 0.11% | Q2 2021 | Q2 2021 | 1 | |
BTAI | BIOXCEL THERAPEUTICS INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2020 | Q2 2020 | 1 |
MRNA | MODERNA INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q1 2021 | Q1 2021 | 1 |
BFLYWS | BUTTERFLY NETWORK INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q1 2021 | Q1 2021 | 1 |
INTEGER HLDGS CORP | 1 | 1 | 0.10% | 0.10% | 0.10% | Q1 2022 | Q1 2022 | 1 | |
CORBUS PHARMACEUTICALS... | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2021 | Q2 2021 | 1 | |
CMLF | CM LIFE SCIENCES INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q4 2020 | Q4 2020 | 1 |
ADVM | ADVERUM BIOTECHNOLOGIE... | 1 | 1 | 0.09% | 0.09% | 0.09% | Q3 2019 | Q3 2019 | 1 |
MANNKIND CORP | 1 | 1 | 0.09% | 0.09% | 0.09% | Q3 2021 | Q3 2021 | 1 | |
DOCS | DOXIMITY INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q2 2021 | Q2 2021 | 1 |
ABCO | ADVISORY BRD CO | 1 | 1 | 0.09% | 0.09% | 0.09% | Q2 2017 | Q2 2017 | 1 |
KODIAK SCIENCES INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q3 2022 | Q3 2022 | 1 | |
ATARA BIOTHERAPEUTICS INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q2 2022 | Q2 2022 | 1 | |
KODIAK SCIENCES INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q4 2021 | Q4 2021 | 1 | |
BFLY | BUTTERFLY NETWORK INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q1 2021 | Q1 2021 | 1 |
AVEO | AVEO PHARMACEUTICALS INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q2 2017 | Q2 2017 | 1 |
ADAPTHEALTH CORP | 1 | 1 | 0.09% | 0.09% | 0.09% | Q4 2021 | Q4 2021 | 1 | |
IGM BIOSCIENCES INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q1 2022 | Q1 2022 | 1 | |
BLI | BERKELEY LTS INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q4 2020 | Q4 2020 | 1 |
BHC | BAUSCH HEALTH COS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q3 2021 | Q3 2021 | 1 |
LEGN | LEGEND BIOTECH CORP | 1 | 1 | 0.08% | 0.08% | 0.08% | Q2 2020 | Q2 2020 | 1 |
KPTI | KARYOPHARM THERAPEUTIC... | 1 | 1 | 0.08% | 0.08% | 0.08% | Q1 2019 | Q1 2019 | 1 |
RAPT | RAPT THERAPEUTICS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q3 2020 | Q3 2020 | 1 |
CYTK | CYTOKINETICS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q2 2018 | Q2 2018 | 1 |
RETA | REATA PHARMACEUTICALS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q3 2022 | Q3 2022 | 1 |
IOVA | IOVANCE BIOTHERAPEUTIC... | 1 | 1 | 0.08% | 0.08% | 0.08% | Q3 2022 | Q3 2022 | 1 |
ZYNE | ZYNERBA PHARMACEUTICAL... | 1 | 1 | 0.08% | 0.08% | 0.08% | Q2 2020 | Q2 2020 | 1 |
STSA | SATSUMA PHARMACEUTICAL... | 1 | 1 | 0.08% | 0.08% | 0.08% | Q2 2020 | Q2 2020 | 1 |
DFFN | DIFFUSION PHARMACEUTIC... | 1 | 1 | 0.08% | 0.08% | 0.08% | Q2 2017 | Q2 2017 | 1 |
CANO HEALTH INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q3 2021 | Q3 2021 | 1 | |
SBTX | SILVERBACK THERAPEUTIC... | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2020 | Q4 2020 | 1 |
HTBX | HEAT BIOLOGICS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q1 2016 | Q1 2016 | 1 |
SEER INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2022 | Q4 2022 | 1 | |
ACAD | ACADIA PHARMACEUTICALS... | 1 | 1 | 0.07% | 0.07% | 0.07% | Q1 2021 | Q1 2021 | 1 |
RADIUS HEALTH INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q2 2022 | Q2 2022 | 1 | |
GLUE | MONTE ROSA THERAPEUTIC... | 1 | 1 | 0.07% | 0.07% | 0.07% | Q2 2021 | Q2 2021 | 1 |
IIN | INTRICON CORP | 1 | 1 | 0.07% | 0.07% | 0.07% | Q1 2019 | Q1 2019 | 1 |
NANO X IMAGING LTD | 1 | 1 | 0.07% | 0.07% | 0.07% | Q1 2022 | Q1 2022 | 1 | |
PERSONALIS INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q2 2021 | Q2 2021 | 1 | |
VXRT | VAXART INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q1 2021 | Q1 2021 | 1 |
PTON | PELOTON INTERACTIVE INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q1 2022 | Q1 2022 | 1 |
FREQ | FREQUENCY THERAPEUTICS... | 1 | 1 | 0.07% | 0.07% | 0.07% | Q1 2021 | Q1 2021 | 1 |
RELMADA THERAPEUTICS INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q2 2022 | Q2 2022 | 1 | |
NVAX | NOVAVAX INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q2 2021 | Q2 2021 | 1 |
CRDF | CARDIFF ONCOLOGY INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q4 2020 | Q4 2020 | 1 |
ZYXI | ZYNEX INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q4 2020 | Q4 2020 | 1 |
COMPUGEN LTD | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2021 | Q2 2021 | 1 | |
INCYTE CORP | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2021 | Q3 2021 | 1 | |
EDITAS MEDICINE INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2021 | Q3 2021 | 1 | |
SENS | SENSEONICS HLDGS INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q4 2020 | Q4 2020 | 1 |
EDITAS MEDICINE INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2021 | Q3 2021 | 1 | |
MORF | MORPHIC HLDG INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q4 2020 | Q4 2020 | 1 |
APTOSE BIOSCIENCES INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2019 | Q2 2019 | 1 | |
ORGANOGENESIS HLDGS INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2023 | Q3 2023 | 1 | |
VRNA | VERONA PHARMA PLC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2022 | Q3 2022 | 1 |
LIQUIDIA CORPORATION | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2022 | Q2 2022 | 1 | |
INSPIREMD INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2023 | Q3 2023 | 1 | |
SESN | SESEN BIO INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q4 2018 | Q4 2018 | 1 |
NUVB | NUVATION BIO INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2021 | Q3 2021 | 1 |
RUBIUS THERAPEUTICS INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2022 | Q1 2022 | 1 | |
NVTA | INVITAE CORP | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2021 | Q1 2021 | 1 |
THORNE HEALTHTECH INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2021 | Q3 2021 | 1 | |
IONS | IONIS PHARMACEUTICALS INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q4 2021 | Q4 2021 | 1 |
PTGX | PROTAGONIST THERAPEUTI... | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2022 | Q1 2022 | 1 |
COMPUGEN LTD | 1 | 1 | 0.05% | 0.05% | 0.05% | Q2 2021 | Q2 2021 | 1 | |
AMWL | AMERICAN WELL CORP | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2021 | Q1 2021 | 1 |
CGEN | COMPUGEN LTD | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2021 | Q1 2021 | 1 |
PLIANT THERAPEUTICS INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q2 2022 | Q2 2022 | 1 | |
CMRX | CHIMERIX INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q2 2022 | Q2 2022 | 1 |
CRMD | CORMEDIX INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q4 2014 | Q4 2014 | 1 |
LUCIRA HEALTH INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q4 2021 | Q4 2021 | 1 | |
CRBP | CORBUS PHARMACEUTICALS... | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2020 | Q3 2020 | 1 |
RCUS | ARCUS BIOSCIENCES INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2021 | Q1 2021 | 1 |
APRE | APREA THERAPEUTICS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2021 | Q4 2021 | 1 |
NGM BIOPHARMACEUTICALS... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2022 | Q3 2022 | 1 | |
VAXART INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q2 2021 | Q2 2021 | 1 | |
SUMMIT THERAPEUTICS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2022 | Q4 2022 | 1 | |
ARCT | ARCTURUS THERAPEUTICS ... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2022 | Q4 2022 | 1 |
SGTX | SIGILON THERAPEUTICS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2020 | Q4 2020 | 1 |
FIELD TRIP HEALTH LTD | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2021 | Q3 2021 | 1 | |
DCTH | DELCATH SYS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2020 | Q4 2020 | 1 |
HIIIU | HUDSON EXECUTIVE INVES... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2021 | Q1 2021 | 1 |
HCIIU | HUDSON EXECUTIVE INVS ... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2021 | Q1 2021 | 1 |
AGLY | AGILITI INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2022 | Q3 2022 | 1 |
ARROWHEAD PHARMACEUTIC... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2022 | Q4 2022 | 1 | |
IDYA | IDEAYA BIOSCIENCES INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2021 | Q1 2021 | 1 |
ONCR | ONCORUS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2021 | Q1 2021 | 1 |
CVAC | CUREVAC N V | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2022 | Q4 2022 | 1 |
ALT | ALTIMMUNE INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2021 | Q1 2021 | 1 |
REPARE THERAPEUTICS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2021 | Q3 2021 | 1 | |
STEVANATO GROUP S P A | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2022 | Q4 2022 | 1 | |
CAPA | HIGHCAPE CAP ACQUISITI... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2021 | Q1 2021 | 1 |
CALA | CALITHERA BIOSCIENCES INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2020 | Q4 2020 | 1 |
INVITAE CORP | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2022 | Q4 2022 | 1 | |
MACK | MERRIMACK PHARMACEUTIC... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2022 | Q4 2022 | 1 |
ROIVANT SCIENCES LTD | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2021 | Q4 2021 | 1 | |
CARDINAL HEALTH INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2022 | Q1 2022 | 1 | |
CCXI | CHEMOCENTRYX INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2021 | Q4 2021 | 1 |
BCTG | BCTG ACQUISITION CORP | 1 | 1 | 0.04% | 0.04% | 0.04% | Q2 2021 | Q2 2021 | 1 |
VERA | VERA THERAPEUTICS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2022 | Q4 2022 | 1 |
CODX | CO-DIAGNOSTICS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2020 | Q3 2020 | 1 |
89BIO INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2022 | Q4 2022 | 1 | |
ETNB | 89BIO INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2022 | Q4 2022 | 1 |
VIR | VIR BIOTECHNOLOGY INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2021 | Q4 2021 | 1 |
OLMA | OLEMA PHARMACEUTICALS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2021 | Q4 2021 | 1 |
SENS | SENSEONICS HLDGS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2020 | Q4 2020 | 1 |
CMPS | COMPASS PATHWAYS PLC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2021 | Q1 2021 | 1 |
ALTIMMUNE INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2021 | Q2 2021 | 1 | |
SAVA | CASSAVA SCIENCES INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2020 | Q3 2020 | 1 |
DTIL | PRECISION BIOSCIENCES INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2021 | Q1 2021 | 1 |
CLOVIS ONCOLOGY INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2022 | Q2 2022 | 1 | |
FHTX | FOGHORN THERAPEUTICS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2021 | Q3 2021 | 1 |
MIRATI THERAPEUTICS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2022 | Q4 2022 | 1 | |
CLEARSIDE BIOMEDICAL INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2021 | Q3 2021 | 1 | |
AGENUS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2022 | Q1 2022 | 1 | |
FOMX | FOAMIX PHARMACEUTICALS... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2017 | Q1 2017 | 1 |
GLYCOMIMETICS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2022 | Q4 2022 | 1 | |
FREQ | FREQUENCY THERAPEUTICS... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2021 | Q1 2021 | 1 |
FREQ | FREQUENCY THERAPEUTICS... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2021 | Q1 2021 | 1 |
OYST | OYSTER PT PHARMA INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2021 | Q4 2021 | 1 |
CARDIOVASCULAR SYS INC... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2021 | Q3 2021 | 1 | |
JOUNCE THERAPEUTICS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2022 | Q3 2022 | 1 | |
ENVB | ENVERIC BIOSCIENCES INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2021 | Q4 2021 | 1 |
UROV | UROVANT SCIENCES LTD | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2018 | Q3 2018 | 1 |
AGLE | AEGLEA BIOTHERAPEUTICS... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2022 | Q4 2022 | 1 |
MERRIMACK PHARMACEUTIC... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2022 | Q4 2022 | 1 | |
ACRS | ACLARIS THERAPEUTICS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2020 | Q4 2020 | 1 |
CUE HEALTH INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2022 | Q1 2022 | 1 | |
THERAVANCE BIOPHARMA INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2021 | Q3 2021 | 1 | |
XENON PHARMACEUTICALS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2021 | Q3 2021 | 1 | |
LVTX | LAVA THERAPEUTICS NV | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2021 | Q1 2021 | 1 |
KARUNA THERAPEUTICS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2022 | Q2 2022 | 1 | |
MCRB | SERES THERAPEUTICS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2021 | Q2 2021 | 1 |
HEXO | HEXO CORP | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2019 | Q4 2019 | 1 |
BCRX | BIOCRYST PHARMACEUTICA... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2020 | Q3 2020 | 1 |
CHEMOCENTRYX INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2021 | Q3 2021 | 1 | |
TXMD | THERAPEUTICSMD INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2022 | Q1 2022 | 1 |
HECCW | HUDSON EXECUTIVE INVT ... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2021 | Q1 2021 | 1 |
CONCERT PHARMACEUTICAL... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2022 | Q4 2022 | 1 | |
LGVN | LONGEVERON INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2021 | Q2 2021 | 1 |
RNA | AVIDITY BIOSCIENCES INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2022 | Q3 2022 | 1 |
ONTX | ONCONOVA THERAPEUTICS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2021 | Q3 2021 | 1 |
ALRN | AILERON THERAPEUTICS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2019 | Q3 2019 | 1 |
SLDB | SOLID BIOSCIENCES INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2021 | Q1 2021 | 1 |
CULLINAN ONCOLOGY INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2022 | Q1 2022 | 1 | |
MIND MEDICINE MINDMED INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2021 | Q3 2021 | 1 | |
PROVENTION BIO INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2022 | Q3 2022 | 1 | |
TARS | TARSUS PHARMACEUTICALS... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2021 | Q2 2021 | 1 |
PAND | PANDION THERAPEUTICS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2020 | Q3 2020 | 1 |
CMLFW | CM LIFE SCIENCES INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2021 | Q1 2021 | 1 |
ARDELYX INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2022 | Q3 2022 | 1 | |
STRO | SUTRO BIOPHARMA INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2022 | Q4 2022 | 1 |
KROS | KEROS THERAPEUTICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2020 | Q4 2020 | 1 |
EDIT | EDITAS MEDICINE INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2021 | Q3 2021 | 1 |
ABUS | ARBUTUS BIOPHARMA CORP | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2021 | Q3 2021 | 1 |
ALTIMMUNE INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2021 | Q3 2021 | 1 | |
IDRA | IDERA PHARMACEUTICALS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2021 | Q1 2021 | 1 |
FGEN | FIBROGEN INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2021 | Q3 2021 | 1 |
IONIS PHARMACEUTICALS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2021 | Q3 2021 | 1 | |
APVO | APTEVO THERAPEUTICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2020 | Q4 2020 | 1 |
BCLI | BRAINSTORM CELL THERAP... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2021 | Q3 2021 | 1 |
GLSI | GREENWICH LIFESCIENCES... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2022 | Q3 2022 | 1 |
ELGX | ENDOLOGIX INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2016 | Q4 2016 | 1 |
BYSI | BEYONDSPRING INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2021 | Q3 2021 | 1 |
BRAINSTORM CELL THERAP... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2021 | Q3 2021 | 1 | |
OCUP | OCUPHIRE PHARMA INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2021 | Q1 2021 | 1 |
MAACW | MONTES ARCHIMEDES ACQU... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2021 | Q3 2021 | 1 |
ARCUS BIOSCIENCES INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2021 | Q2 2021 | 1 | |
LEXICON PHARMACEUTICAL... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2021 | Q2 2021 | 1 | |
LIPOCINE INC NEW | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2021 | Q2 2021 | 1 | |
BEYONDSPRING INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2021 | Q3 2021 | 1 | |
PRLD | PRELUDE THERAPEUTICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2020 | Q3 2020 | 1 |
PROQR THRAPEUTICS N V | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2022 | Q1 2022 | 1 | |
IDRA | IDERA PHARMACEUTICALS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2021 | Q1 2021 | 1 |
HARP | HARPOON THERAPEUTICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2020 | Q4 2020 | 1 |
BIVI | BIOVIE INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2022 | Q3 2022 | 1 |
MEDAVAIL HOLDINGS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2023 | Q3 2023 | 1 | |
RELMADA THERAPEUTICS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2022 | Q4 2022 | 1 | |
LPTX | LEAP THERAPEUTICS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2021 | Q3 2021 | 1 |
PHAS | PHASEBIO PHARMACEUTICA... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2021 | Q3 2021 | 1 |
LPCN | LIPOCINE INC NEW | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2021 | Q2 2021 | 1 |
KTRA | KINTARA THERAPEUTICS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2021 | Q2 2021 | 1 |
EVAX | EVAXION BIOTECH A S | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2022 | Q4 2022 | 1 |
PRFX | PAINREFORM LTD | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2020 | Q4 2020 | 1 |
OTIC | OTONOMY INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2020 | Q3 2020 | 1 |
Download |
The securities at the top of the list , including ICU MED INC, NANOSTRING TECHNOLOGIES INC, and VIEWRAY INC, are the highest-conviction holdings of PURA VIDA INVESTMENTS, LLC.
The conviction is calculated by counting the number of quarters a security has been reported by PURA VIDA INVESTMENTS, LLC. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that PURA VIDA INVESTMENTS, LLC owns currently or has owned in the past.